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Modulation of small RNA silencing by cross-generational signaling in C. elegans 
 
Abstract 
 
Organisms are constantly challenged by the surrounding environment and alter 
their physiology accordingly. Some environment-induced changes in one generation are 
inherited in the offspring, and this long-lasting memory of parental experience has gained 
a lot of attention recently due to its implications in the organism’s development and 
health. One example is transmission of RNAi-induced silencing from parents to progeny 
in C. elegans. Although this phenomenon has been known for more than a decade, the 
parental contribution to RNAi inheritance is still unclear. Here, we show that the nuclear 
hormone receptor DAF-12 mediates a cross-generational signaling that regulates RNAi in 
zygotes. Pol II ChIP-qPCR revealed that normally, DAF-12 enhances transcriptional 
repression induced by RNAi. Mutant analysis demonstrated that the role of DAF-12 in 
RNAi is distinct from its function in developmental timing or heterochronic pathways. 
Surprisingly, DAF-12 acts in mothers to alter the RNAi efficiency in zygotes, indicating 
the presence of mother-to-offspring, DAF-12-dependent signals that enhance RNAi in 
zygotes. Considering the previous studies showing that the function of DAF-12 is 
determined by environmental cues, we tested and found that the role of DAF-12 in RNAi 
enhancement in zygotes depends on the environmental cues presented to mothers during 
their development. These results demonstrate a novel role of DAF-12 as a modulator of 
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RNAi and its contribution to cross-generational signaling. Moreover, the findings imply a 
potential interaction between environmental conditions and small RNA pathways. 
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CHAPTER I 
Background 
 
Transmission of environmental information from parents to offspring 
In the past few decades, studies have shown a strong causative relationship between 
parental experience of environmental conditions and the abnormal phenotypes of their 
offspring without any genetic mutations. Both invertebrates and vertebrates exhibit such 
inheritance, and a range of environmental factors can act as a trigger. This 
unconventional inheritance began to receive a lot of attention due to its implications for 
human health, particularly obesity and heart disease. The identities of the molecules 
mediating the transmission of the environmental effect to offspring are under rigorous 
investigation. Epigenetic molecules, such as DNA methylation, small non-coding RNAs 
and histone modifications, have been suggested as strong candidates, but most studies 
have uncovered a correlation, not causality, between alteration in non-genetic molecules 
and phenotypic changes. Here, I summarize the cases where transient environmental 
conditions during the parental generation affect the subsequent generation. Following 
sections are the excerpts (with some modifications) from the review article “Hunting for 
Darwin’s gemmules and Lamarck’s fluid: transgenerational signaling and histone 
methylation” submitted to BBA Gene Regulatory Mechanisms. 
 
Food and nutrients 
Studies exploiting historical statistics and health records of individuals in Sweden have 
shown a strong correlation between food availability for grandfathers just prior to the 
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onset of puberty, and the longevity and risks for cardiovascular and metabolic diseases of 
their descendants (KAATI et al. 2002, 2007). When paternal grandfathers received 
plentiful food during the slow growth period prior to puberty, the descendants had a four-
fold greater incidence of mortality from diabetes (KAATI et al. 2002). Another frequently 
cited example for inherited effects with humans is the Dutch Hunger Winter during 
World War II. A food embargo imposed by the Nazis on the uncooperative Dutch 
citizens resulted in a devastating famine during the winter of 1944-1945 (ZEE 1998; 
SCHULZ 2010). Although the famine lasted approximately five months, studies found that 
people who were exposed to the famine prenatally had a high incidence of health defects 
more than 50 years later. They were more likely to develop adult-onset diseases and 
experience a decline in their cognitive ability earlier, compared to their unexposed 
siblings (ROSEBOOM et al. 2006; DE ROOIJ et al. 2010; SCHULZ 2010).  
To understand how a short period of starvation could induce health problems 
across generations, researchers developed and examined model organisms. Dunn and 
Bale (2009) reported that a high fat diet given to mice during pregnancy produced 
offspring (F1) with high body weight and low insulin sensitivity (DUNN and BALE 2009). 
These F1 animals were fed normally during development and pregnancy, yet their 
offspring (F2) also exhibited problems with insulin insensitivity (DUNN and BALE 2009).  
Non-genetic inheritance can be induced from fathers and grandfathers. In a study 
by Fullston and colleagues, male mice fed a high-fat diet for ten weeks before mating 
produced F1 offspring with impaired glucose tolerance and insulin sensitivity (FULLSTON 
et al. 2013). Interestingly, obesity- and diabetes-related complications were more severe 
in F1 females than in F1 males, suggesting a gender bias (FULLSTON et al. 2013). In the 
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next generation, F2 females from the F1 males exhibited high body fat and insulin 
resistance (FULLSTON et al. 2013). The phenotypes observed in health and longevity were 
matched by changes in the expression of metabolic genes. For example, Ng and 
colleagues found that mice fed a high fat diet produced F1 female offspring with altered 
expression of genes important for insulin function and glucose metabolism (NG et al. 
2010). Similarly, when male mice experienced a diet high in sugar and low in protein, the 
offspring had altered expression of genes for lipid and cholesterol metabolism (CARONE 
et al. 2010). Together, the amounting data suggest that non-genetic inheritance is 
responsible for alterations in metabolism across generations.  
 
Toxins 
Exposure to vinclozolin is one of the best-characterized examples of non-genetic 
inheritance from an environmental compound (ANWAY et al. 2005). Vinclozolin is a 
fungicide that interrupts endocrine signaling pathways and has long-lasting effects on 
future generations. When a gestating female rat is exposed to vinclozolin, her male F1 
progeny exhibit a reduction in the number and motility of their sperm, leading to defects 
in reproduction that persist until the F4 generation (ANWAY et al. 2005). Other 
environmental compounds including di-(2-ethylhexyl) phthalate (a chemical component 
of plastics), pesticides, and jet fuel are also known to cause reproductive defects in 
progeny of the parents who are directly exposed to these chemicals (MANIKKAM et al. 
2012; DOYLE et al. 2013). This finding highlights the abiding dangers of these chemicals 
for the ecosystem and human health.  
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Drosophila has provided good examples of inheritance of drug-induced 
phenotypes. Pentylenetetrazole is a GABA antagonist that induces epileptic seizures 
(KUPFERBERG 2001). A study using Drosophila as a model for epileptogenesis 
discovered that pentylenetetrazole treatment alters expression of genes in the central 
nervous system (MOHAMMAD et al. 2009). Strikingly, grandchildren of 
pentylenetetrazole-treated male Drosophila showed expression profiles that were similar 
to those of the P0 flies, indicating the potency of this chemical in subsequent generations 
(SHARMA and SINGH 2009).  
Stern et al (2012) used a Drosophila strain that was genetically engineered to 
express G418-resistant genes globally or in a specific area. The response to exposure to 
G418, an antibiotic that blocks translation, included elevated expression of some genes, 
expansion of spatial expression patterns, and delays in development (STERN et al. 2012). 
These phenotypes were inherited in subsequent generations, although the descendants 
were not exposed to G418 (STERN et al. 2012).  Thus, toxins can induce long lasting 
changes to gene expression over generations. 
 
Olfactory experience and stress 
The memory of a certain odor during early development can last long into adulthood. 
Using C. elegans, a roundworm with a simple nervous system, Remy and Hobert showed 
that adult animals exhibit strong responses to chemical attractants to which they were 
exposed during early larval development (REMY and HOBERT 2005). F1 offspring of 
parents who were exposed to olfactory cues also exhibited an enhanced attraction to the 
cues. 
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Mammals with more neurons and more complex neural circuitry than C. elegans 
also transmit olfactory memory to future generations. In a study led by Dias and Ressler, 
exposure to an odor (acetonphenone) was paired with a burst of noise that induced a 
startle response (DIAS and RESSLER 2013). F1 and F2 offspring of male P0 mice that had 
learned to link the odor with the noise, showed an increased startle response towards the 
conditioning odor, despite their naiveté towards the trigger (DIAS and RESSLER 2013). In 
addition to behavioral changes, neuroanatomical characteristics of the conditioned P0 
mice were also inherited in the F1 and F2 generations (DIAS and RESSLER 2013). F1 
progeny conceived by in vitro fertilization behaved like other animals conceived by 
mating, indicating that transmission of the memory of the odor-noise link occurred via 
gametes (DIAS and RESSLER 2013).  
Postnatal exposure to stress and separation from mothers are strongly linked to 
anxiety and depression in adulthood (reviewed in (WEISS et al. 2011)), and this traumatic 
stress in early life can influence behaviors in future generations. Grandchildren (F3) of F1 
mice who were raised under chronic stress from maternal separation exhibited 
depression-like behaviors, although they had not suffered from the same poor maternal 
care (FRANKLIN et al. 2010). 
 
The role of small noncoding RNA pathway in non-genetic inheritance of C. elegans 
RNAi-mediated transcriptional repression and RNAi inheritance in C. elegans 
RNA interference (RNAi) is a gene silencing process triggered by double-stranded RNAs 
(dsRNAs). dsRNAs that are either endogenously expressed or experimentally introduced 
are cleaved to generate 21- to 25- nucleotide small interfering RNAs (siRNAs) 
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(ELBASHIR et al. 2001; BERNSTEIN et al. 2001). These primary siRNAs bind to the target 
transcripts and inhibit the translation (SEN 2006; VALENCIA-SANCHEZ 2006). Primary 
siRNAs also induce the amplification mechanism, where RNA-dependent RNA 
polymerase synthesizes de novo anti-sense mRNA by using the target mRNA as a 
template (SIJEN et al. 2001, 2007). More abundant than primary siRNAs (PAK and FIRE 
2007), secondary siRNAs are crucial for effective RNAi.  
Recently, studies have discovered that RNAi can also induce gene silencing in the 
nucleus (GUANG et al. 2008, 2010; FISCHER 2010). In C. elegans, secondary siRNAs are 
incorporated into a nuclear argonaute NRDE-3, which localizes to the nucleus and 
recruits a conserved nuclear protein NRDE-2 to block transcription of the targeted gene 
(GUANG et al. 2010). NRDE-3 is essential for RNAi targeting only a subset of genes 
(GUANG et al. 2008), indicating that transcriptional silencing is not universally required 
for silencing induced by RNAi. Recently, NRDE-3-dependent silencing gained a lot of 
attention due to its role in inheritance of silenced state triggered by RNAi. Transient 
exposure to dsRNA in parental generation (P0) promotes gene silencing in the subsequent 
generation (F1) and NRDE-3 acts in F1 to retain the memory of silenced state (Fig. 1.1) 
(BURTON et al. 2011; BUCKLEY et al. 2012; GU et al. 2012).  
 Locus-specific enrichment of H3K9me3, a histone modification associated with 
inactive transcription induced by RNAi, is involved in inheritance of RNAi-mediated 
silencing in C. elegans. When P0 animals are exposed to dsRNA, their offspring (F1) and 
grand-offspring (F2) exhibit H3K9me3 enrichment at the targeted locus and RNAi 
phenotypes, even though the trigger dsRNAs are not presented to the F1 and F2  
 
! 7!
 
 
 
Figure 1.1. RNAi-induced silencing response is inherited to the progeny.  
For example, when a transgenic animal expressing GFP (green worm; P0) is fed with 
GFP dsRNA-expressing bacteria, GFP expression is inhibited not only in P0 and but also 
in its progeny (F1) (white worms). A nuclear argonaute NRDE-3 associated with small 
interfering RNAs (siRNA) act in zygotes (F1) to maintain RNAi-induced silencing by 
blocking transcription (GUANG et al. 2008). In addition to siRNAs, H3K9me3 
modification is enriched at the locus targeted by the initial dsRNA (GUANG et al. 2010; 
GU et al. 2012). 
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(GU et al. 2012). Moreover, H3K9 methyltransferases SET-25 and SET-32 are known to 
be required for heritable RNAi (ASHE et al. 2012). Does H3K9me3 act as a physical 
signal transmitting the memory of RNAi-induced silenced state across generations? It 
appears not. Temporal analysis of siRNAs and H3K9me3 in the progeny (F1) of RNAi-
treated worms (P0) showed that H3K9me3 appeared at later developmental stages 
compared to siRNAs, indicating that H3K9me3 was re-established in the progeny, not 
transmitted from the previous generation (BURTON et al. 2011).  
 
Other small RNA pathways in C. elegans that are involved in the transmission of gene 
expression states across generations 
In addition to the exogenous RNAi pathway, C. elegans employs other small RNA 
pathways to maintain transcriptional states across generations In the C. elegans germ line, 
transgenes tend to be silenced robustly and this is mediated by piRNAs, one of the major 
classes of small RNAs. Unlike the aforementioned primary and secondary siRNAs, 
piRNAs are genetically encoded and largely, but not exclusively, expressed in the germ 
line (LIN 2007). PRG-1, a C. elegans Piwi protein involved in the biogenesis of piRNAs 
(BAGIJN et al. 2012; LEE et al. 2012), is required to trigger silencing of a transgene in the 
germ line (ASHE et al. 2012; SHIRAYAMA et al. 2012). Once activated, the piRNA 
pathway induces the production of another class of small RNAs known as 22G-RNAs, 
which are loaded onto different argonautes and maintain the silenced state of the 
transgene over multiple generations (BAGIJN et al. 2012; LEE et al. 2012).  
Not only is silencing remembered, but also gene activity. Recent studies have 
uncovered an “anti-silencing” pathway that involves a different cohort of 22G-RNAs 
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(CLAYCOMB et al. 2009; SETH et al. 2013; WEDELES et al. 2013). Seth et al (2013) and 
Wedeles et al (2013) relied on transgenes and discovered that an actively expressed 
transgene not only maintained its active transcriptional state, but could also de-repress a 
silenced transgene that shared sequence identity (SETH et al. 2013; WEDELES et al. 2013). 
This phenomenon (known as RNA-induced epigenetic gene activation or RNAa) is 
mediated by the argonaute CSR-1 (CLAYCOMB et al. 2009; SETH et al. 2013; WEDELES et 
al. 2013) (Fig. 1.2). Given that piRNAs and 22G-RNAs target endogenous genes 
(CLAYCOMB et al. 2009; BAGIJN et al. 2012; LEE et al. 2012), small RNA pathways 
appear to play a crucial role in transmitting the memory of endogenous vs. foreign gene 
expression from one generation to the other. While these pathways were discovered using 
transgenes, the phenotypes of argonaute mutants (e.g. csr-1 and alg-3/alg-4) and some 
RNAi-hypersensitive mutants (e.g. eri-1 and rrf-3) indicate a critical role in 
gametogenesis (PAVELEC et al. 2009; CONINE et al. 2010, 2013). 
 
Steroid hormone signaling pathway in C. elegans 
My thesis reveals a new role of the C. elegans nuclear hormone receptor (NHR) DAF-12 
in RNAi. NHR are transcription factors whose activity depends on ligands and on 
interacting partners; when lipophilic hormones bind to an NHR, it recruits various 
chromatin modeling enzymes and transcription co-activators to promote expression of 
downstream genes. In contrast, interactions between NHRs and their co-repressors result 
in repression of target genes. Humans and Drosophila each have fewer than 50 NHRs, 
whereas there are more than 284 NHRs in the genome of C. elegans (SLUDER and MAINA 
2001; GISSENDANNER et al. 2004).  
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Figure 1.2. The role of CSR-1/Argonaute in transactivation of silenced gene.  
In C. elegans, the many transgenes expressed in the germ line are susceptible to silencing 
(SHIRAYAMA et al. 2012). Transgenes that are active are associated with H3K4me2 (blue; 
generally considered as a mark of active transcription) whereas transgenes that are 
silenced are enriched for H3K9me3 (red; a histone modification linked to silenced loci) 
(WEDELES et al. 2013). When an animal carrying a silenced transgene (gfp1) is mated 
with a worm carrying actively transcribed transgene (gfp2), the resulting F1 inherits 
CSR-1/Argonaute from the gfp2-expressing P0 animal.  In F1, CSR-1 counteracts the 
surveillance mechanism that silences gfp1 expression (1) (SETH et al. 2013; WEDELES et 
al. 2013). In addition, RNA-induced epigenetic silencing (RNAe), where the surveillance 
mechanism acting on a genetic locus targets another locus with similar DNA sequence 
(SHIRAYAMA et al. 2012), is inhibited by CSR-1 (2) (WEDELES et al. 2013). The 
observation that csr-1 -/- mutants lack H3K4me2 in germline (CONINE et al. 2013) 
indicates that CSR-1 activity is correlated with H3K4me2 enrichment (3). Owing to the 
activity of CSR-1 bestowed by the animal expressing gfp2, the silenced state of gfp1 is 
reversed to the active transcription state and gfp2 is protected from silencing mechanism 
in F1. Even when gfp2 is removed in F2, the memory of gfp1 transcription is inherited, 
thus gfp1 remains to be expressed. Although it remains to be seen, we expect that 
accumulation of H3K4me2 would accompany the reversal of a silenced transgene to 
active transcription. 
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Figure 1.2 (continued). The role of CSR-1/Argonaute in transactivation of silenced 
gene. 
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As a nuclear hormone receptor, DAF-12 binds to the promoter regions of target 
genes and, depending on its binding partner, DAF-12 acts as an activator or a repressor 
(AO et al. 2004; SHOSTAK et al. 2004; FISHER and LITHGOW 2006; HOCHBAUM et al. 
2011). One of the unique characteristics of DAF-12 is its link to the environmental 
conditions. Pathways that respond to environmental cues converge at DAF-12 (reviewed 
in (FIELENBACH and ANTEBI 2008)), indicating its role in mediating physiological 
changes in response to environmental conditions. Here, I discuss the regulation of the 
DAF-12 activity and its roles in C. elegans development. 
 
Ligands 
The level of Dafachronic acid (DA; 3-keto-sterols) determines the function of DAF-12. 
Dafachronic acids are the first steroid hormone discovered as a ligand of NHR in 
nematodes (MOTOLA et al. 2006; MAHANTI et al. 2014). Their precursors are dietary 
cholesterol, which is metabolized through successive oxidation by multiple enzymes. The 
enzyme network required for DA synthesis from cholesterol is rather complex and 
divergent. Enzymes are expressed in different tissues, including the intestine, the XXX 
neuroendocrine cells and the hypodermis (OHKURA et al. 2003; ROTTIERS et al. 2006; 
SCHAEDEL et al. 2012). A small amount of DA produced in the XXX neuroendocrine 
cells located in the head increases the production of DA in the hypodermis, and this 
amplification allows animals to make a binary and irreversible decision—reproductive 
growth or dauer entry—in response to a small change in the DA synthesis (SCHAEDEL et 
al. 2012).  
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In the presence of its ligands, NHRs interact with co-activators, which facilitate 
the transcriptional activity of NHRs. When expressed in mammalian cells, DAF-12 binds 
to steroid receptor coactivator 1, but its endogenous coactivator has not bee identified yet 
(MOTOLA et al. 2006; MAHANTI et al. 2014).  
 
Co-repressor DIN-1 
Another important domain in DAF-12 is a site where its co-repressor DIN-1S binds. 
DIN-1S binding site is embedded in the LBD, and the presence of DA disassociates DIN-
1S from DAF-12 (MOTOLA et al. 2006). Repressor activity of DIN-1S was first inferred 
from its similarity to human SMRT/HDAC-1-associated repressor protein (SHARP). 
Mammalian studies have shown that through its highly conserved C-terminal domain, 
SHARP interacts with transcriptional repressors, such as SMRT and nuclear receptor co-
repressors (NCoR) and consequently recruits histone deacetylase (HDAC) (SHI 2001; 
MIKAMI et al. 2014). SHARP binds to unliganded nuclear hormone receptors and 
represses their transcriptional activity (SHI 2001; SHI et al. 2002). Yeast-two hybrid 
experiments have shown that DIN-1S binds to DAF-12, and the mutant analysis revealed 
that the dauer phenotype of daf-12 mutants was dependent on DIN-1S. Together, 
previous works strongly suggest that DIN-1S is a co-repressor for DAF-12 (LUDEWIG et 
al. 2004). 
 
Expression pattern of DAF-12 
Two independent studies using either GFP fused to the daf-12 promoter or Northern blot 
analysis reported that daf-12 is expressed from mid-embryogenesis to adulthood (ANTEBI 
! 14!
et al. 2000; SNOW and LARSEN 2000). The long and short isoforms of daf-12 have similar 
temporal expression patterns (SNOW and LARSEN 2000). daf-12 is expressed in many 
tissues including neurons, intestine, pharynx and somatic gonad (ANTEBI et al. 2000). 
Studies that profiled the transcriptome in the germ line and early embryos did not detect 
daf-12 mRNA (BAUGH et al. 2003; REINKE et al. 2003; YUZYUK et al. 2009; LEVIN et al. 
2012). These results indicate that no or few daf-12 transcripts are maternally loaded into 
oocytes and able to function in early embryos. 
 
Biological roles of DAF-12 
As a part of the endocrine system in C. elegans, DAF-12 plays a crucial role in the 
processes that require systemic changes, such as larval development, aging, and immune 
responses. DAF-12 binds to the promoter regions of target genes and, depending on its 
binding partner, DAF-12 acts as an activator or a repressor (AO et al. 2004; SHOSTAK et 
al. 2004; FISHER and LITHGOW 2006; HOCHBAUM et al. 2011). It is important to note here 
that studies up to date mainly focused on the role of DAF-12 during the development of 
one generation. My thesis reveals that DAF-12 is also involved in cross-generational 
signaling. . 
 
Dauer entry  
daf-12 was first discovered from the EMS mutagenesis screening designed to identify 
mutants defective in the dauer larval formation (daf) (RIDDLE et al. 1981). Once hatched, 
C. elegans normally go through four larval stages and become reproductive adults. 
However, if animals encounter an unfavorable environment, such as overcrowding, 
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scarce food and/or high temperature, they choose an alternative third larval stage called 
the dauer (FIELENBACH and ANTEBI 2008). Dauers remodel their cuticle (CASSADA and 
RUSSELL 1975), suppress pharyngeal pumping (CASSADA and RUSSELL 1975), and 
oxidize stored fat to produce energy (WADSWORTH and RIDDLE 1989). These 
physiological and metabolic changes allow dauers to tolerate harsh environmental 
conditions better than developing larvae and can survive for months (CASSADA and 
RUSSELL 1975). Once the environment becomes favorable, dauers resume reproductive 
growth. 
 The decision whether to grow to adulthood or form a dauer is an excellent 
example of how environmental inputs can influence the development of an organism, and 
DAF-12 acts at a convergence point for different environmental sensing pathways. 
Favorable environmental cues trigger signaling pathways such as insulin and TGF-beta 
pathways (REN et al. 1996; KIMURA et al. 1997). Activation of such pathways leads to 
production of DA, which binds to DAF-12 and promotes larval development (MOTOLA et 
al. 2006; GERISCH et al. 2007; SCHAEDEL et al. 2012; MAHANTI et al. 2014). In contrast, 
unfavorable environments block the biosynthesis of DA (REN et al. 1996; SCHACKWITZ et 
al. 1996; GERISCH et al. 2001), and as a result, a repressor complex of DAF-12 promotes 
dauer formation (LUDEWIG et al. 2004).  
 There are more than twenty daf-12 mutations identified so far and their dauer 
phenotypes largely depend on the nature of the molecular lesions. In general, animals that 
bear mutations in the DNA binding domain cannot form dauer (Daf-d) when challenged 
by unfavorable environmental conditions (ANTEBI et al. 2000). This result indicates that 
DNA binding and presumably transcriptional control is important for dauer entry. 
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Molecular lesions in the LBD lead to either Daf-d or Daf-c (constitutive entry into dauer) 
(ANTEBI et al. 2000), suggesting that a subtle change in the ligand binding domain alters 
the affinity for DA or DIN-1 and consequently affects the dauer phenotype.  
 The role of DAF-12 in mediating the environmental effect on physiological 
changes is conserved in nematodes. The nematode Pristionchus pacificus forms teeth-like 
denticles when they are starved or presented to a high level of pheromone, an indicative 
of high population density (KIONTKE and FITCH 2010). Bento et al (2010) found that the 
formation of a wide stoma with teeth induced by starvation depends on DAF-12 function 
and DA level (BENTO et al. 2010). Taken together, DAF-12 is an integral part of the 
mechanism that translates the environmental signals into physiological changes. 
 
Physiological capacitor 
The role of DAF-12 for dauer entry shows that DAF-12 executes important decisions in 
development. Recently, Hochbaum, Fisher and colleagues reported another example 
showing the executive role of DAF-12. They reared wildtype worms and daf-12 
(rh61rh411; null) mutants while cycling between 15°C (4 hours) and 25°C (4 hours) until 
adulthood (HOCHBAUM et al. 2011). The majority of wildtype worms had the same 
number (16) of hypodermal seam cells as wildtype animals that grew at 20°C, whereas a 
significant portion of daf-12 null mutants that were challenged with temperature 
fluctuations underwent an extra hypodermal seam cell division (HOCHBAUM et al. 2011). 
This observation indicates that DAF-12 buffers perturbations in the surroundings, and 
thus lack of DAF-12 leads to hypersensitivity to even small environmental changes. 
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Developmental timing 
In addition to dauer phenotypes, another prominent trait associated with some, but not all, 
daf-12 mutations is defects in seam cell division and in gonad migration, which normally 
occur at specific larval stages (ANTEBI et al. 1998, 2000). Two independent studies have 
shown that DA-bound DAF-12 promotes the transition from the second larval stage (L2) 
to the third larval stage (L3) by activating let-7 family microRNAs (BETHKE et al. 2009; 
HAMMELL et al. 2009), which down-regulate hbl-1 (hunchback), an essential 
transcription factor for the L2 stage (ABBOTT et al. 2005). In addition to the let-7 family 
of microRNAs, many heterochronic genes, which encode factors essential for 
developmental timing mechanisms, have a DAF-12 binding site in their promoters and 
their expression is altered in daf-12 null mutants (HOCHBAUM et al. 2011). Together these 
studies imply that DAF-12 regulates heterochronic pathways. 
 
Aging 
DAF-12 has drawn a lot of attention recently for its role in inter-organ communication 
involved in aging, particularly in the gonad. When two germline precursor cells are 
ablated during early larval development, C. elegans live longer than germline-intact 
wildtype animals by 60% (HSIN and KENYON 1999; ARANTES-OLIVEIRA et al. 2002). 
Germline-ablated worms require DAF-12 and DAF-9, a cytochrome P450 essential for 
DA synthesis, to extend their lifespan (HSIN and KENYON 1999; GERISCH et al. 2001; 
MOTOLA et al. 2006; ROTTIERS et al. 2006; YAMAWAKI et al. 2010). This discovery 
suggests that DAF-12 and DA act as “anti-aging” factors that promote the longevity of 
germline-deficient animals. How could the DAF-12 pathway prevent aging in response to 
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germline ablation? A recent report discovered that germline ablation elevates the level of 
DA at the fourth larval and young adult stages (SHEN et al. 2012). DA-bound DAF-12 
stimulates the expression of two key microRNAs, mir-84 and mir-241 (SHEN et al. 2012). 
These microRNAs down-regulate their target genes, thus activating DAF-16/FOXO 
signaling (SHEN et al. 2012), a major pathway eliciting the anti-aging effect in germline-
less animals (HSIN and KENYON 1999; LIN et al. 2001; BERMAN and KENYON 2006). In 
addition, DAF-12 activates downstream genes that are distinct from those regulated by 
DAF-16/FOXO, to extend the lifespan of germline-ablated animals (YAMAWAKI et al. 
2010). Taken together, the DA and DAF-12 signaling pathway mediates a systemic effect 
in longevity in C. elegans.  
Another example of DAF-12 inducing systemic physiological changes is relevant 
to mating-triggered shrinking. Shi and Murphy (2013) observed that when 
hermaphrodites were mated with males, they shrank massively and their post-
reproductive longevity was shortened to > 40% of that of unmated hermaphrodites (SHI 
and MURPHY 2013). daf-9 and daf-12 null mutants do not show such phenotypes after 
mating, indicating their roles in mating-triggered changes (SHI and MURPHY 2013). 
Mating decreased the expression of daf-9 in the hermaphrodite’ spermatheca, a part of the 
somatic gonad that stores sperm (SHI and MURPHY 2013). Given that DAF-12 regulates 
the expression of the genes required for osmotic stress resistance (FISHER and LITHGOW 
2006; MCCORMICK et al. 2012), the authors speculated that mating decreases the level of 
liganded DAF-12 in hermaphrodites, which in turn causes post-mating shrinking (SHI and 
MURPHY 2013). The causal link between shrinking and the immediate death after 
reproduction has not been tested yet. However, this study suggests that as an integral part 
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of endocrine system in C. elegans, DAF-12 sets off systemic responses to a local 
signaling cue. 
To summarize, my thesis uncovers a new role for DAF-12 in cross-generational 
signaling that regulates the robustness of RNAi. Previous works highlighting the 
importance of DAF-12 in translating environmental inputs into molecular and 
physiological changes also led us to test and found an interesting link between parental 
experience of a certain environment and RNAi efficiency in offspring. 
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CHAPTER II 
 
The Role of DAF-12/NHR in RNAi regulation via Cross-generational Signaling 
 
Introduction 
Haploid germ cells carry parental genetic information that will constitute the genetic 
makeup of a zygote. In addition to DNA, germ cells have organelles and lots of nuclear 
and cytoplasmic molecules that significantly influence their offspring’s development, 
behavior and health. The classic example is maternal-effect genes, which are expressed 
and packaged as RNA or protein in oocytes, and which play a crucial role in early events 
of embryogenesis (reviewed in (LI et al. 2010)). Another example is mother-to-offspring 
immune priming in vertebrates, where mothers transmit antibodies to their offspring to 
improve their chances of survival (MOUSSEAU and FOX 1998; GRINDSTAFF et al. 2003; 
HASSELQUIST and NILSSON 2009). Thanks to technologies that allow detection of 
miniscule amounts of biological molecules and increasing knowledge about epigenetic 
marks such as histone modifications and DNA methylation, a list of molecules deposited 
in germ cells is ever expanding. More recent studies have suggested that parental 
experiences in different environments can cause abnormal phenotypes in their offspring 
without any genetic mutations. A flurry of studies has attempted to identify non-genetic 
molecules responsible for this non-conventional inheritance, and strong candidates 
include DNA methylation, histone modifications, and small non-coding RNAs (ANWAY 
et al. 2005; JABLONKA and RAZ 2009; BURTON et al. 2011; GREER et al. 2011; BUCKLEY 
et al. 2012; GU et al. 2012; LIM and BRUNET 2013) . 
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Inheritance of gene silencing by RNA interference (RNAi) in C. elegans 
illustrates the memory of transient experiences across generations. RNAi is a cellular 
mechanism that silences a specific gene whose sequence is complementary to double 
stranded RNAs (dsRNAs). In a typical experiment, exogenously introduced long dsRNAs 
are first cleaved into 21- to 25-nucleotide small interfering RNAs (primary siRNAs) 
(ELBASHIR et al. 2001; BERNSTEIN et al. 2001), which bind to the mRNA transcripts of 
the endogenous target and inhibit their expression at the post-transcriptional level (SEN 
2006; VALENCIA-SANCHEZ 2006). Effective RNAi relies on the second class of siRNAs 
(secondary siRNAs), de novo RNA molecules that are synthesized using the targeted 
transcripts as a template and produced by the activity of RNA-dependent RNA 
polymerase (SIJEN et al. 2001, 2007). Secondary RNAis triggers transcriptional gene 
silencing via the nuclear RNAi defective (NRDE) pathway (GUANG et al. 2008). 
Interestingly, exposure of worms (P0) to double-stranded RNA can induce RNAi not 
only in P0 animals, but also across multiple generations (F1, F2, etc) (FIRE et al. 1998; 
GRISHOK et al. 2000; VASTENHOUW et al. 2006; ALCAZAR et al. 2008). The identity of 
heritable molecules responsible for RNAi inheritance is not known yet. However, 
persistence of RNAi is associated with the presence of siRNAs and enrichment of 
H3K9me3 at the locus targeted by the initial trigger dsRNA (BURTON et al. 2011; 
BUCKLEY et al. 2012; GU et al. 2012).  
 Here, we show that DAF-12, a C. elegans nuclear hormone receptor, modulates 
cross-generational RNAi. DAF-12 has well described roles in the response to 
environmental conditions, developmental timing and entry into dauer, a developmental 
! 22!
arrest induced by harsh conditions (ANTEBI et al. 2000; FIELENBACH and ANTEBI 2008; 
BETHKE et al. 2009; HAMMELL et al. 2009). Transcriptional activation and repression by 
DAF-12 depend on its ligand Dafachronic acid (DA)—a metabolite of dietary 
cholesterol—and on the DAF-12 co-repressor DIN-1, respectively (LUDEWIG et al. 2004; 
GILL et al. 2004; MOTOLA et al. 2006; HELD et al. 2006). Whereas previous studies on 
DAF-12 focused on its role in the life history of one generation, we find that DAF-12 in 
mothers promotes transcriptional repression induced by RNAi in her progeny. The 
function of daf-12 in RNAi is independent of its roles in developmental timing and dauer 
entry. We also found that the environmental conditions of the mothers’ larval 
development determines the effect of DAF-12 on RNAi efficiency in zygotes. Together, 
these results demonstrate that maternal DAF-12 not only creates additional layers of 
regulation in RNAi inheritance, but also buffers the environmental contribution to RNAi. 
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Materials and Methods 
Strains and maintenance 
Worms were maintained as described before (BRENNER 1974). SM2020 daf-12 
(rh61rh411) strain used for most of the experiments in this study was outcrossed six times 
and paired with its wildtype sibling (SM2021) for all the experiments. The complete list 
of C. elegans strains used in this study is in Appendix III. Worms were reared at 20°C 
except pha-4(ts) and daf-7(e1372), which were maintained at 24°C and 15°C, 
respectively.  
 
RNA interference (RNAi)  
Bacteria expressing double-stranded RNA were obtained from the Ahringer library 
(KAMATH and AHRINGER 2003) and sequenced to confirm their identities. pha-4 RNAi 
clones made previously by the Mango lab (bSEM 865) (KIEFER et al. 2007) were used for 
most pha-4 RNAi assays except for Pol II ChIP and RT-qPCR experiments, where pha-4 
RNAi clones from the Ahringer library were used. There are two differences between 
bSEM865 and the Ahringer library pha-4 RNAi clones. First, bSEM865 produces pha-4 
dsRNA that is as long as the complete pha-4 transcript, whereas the Ahringer library 
clone generates dsRNA that corresponds to exon 5, intron 5, and exon 6 of the pha-4 
sequence (F38A6.1a). Second, the backbone vector for bSEM865 is pPR244 (REDDIEN et 
al. 2005), while the Ahringer library clone used the L4440 feeding vector (KAMATH and 
AHRINGER 2003).  
RNAi clones were cultured in 5ml LB with antibiotics (final concentration of 
50µg/ml) in 13ml round-bottom tube for 8 hours at 37°C. LB was added to the culture to 
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achieve the optical density (OD) of 1.5. To vary the strength of RNAi, empty vector 
(L4440) or mCherry RNAi clones (bSEM1098; full mCherry sequence is inserted into 
pPR244) were added to the RNAi culture. The mixture was spun down at 2500rpm for 
10min and resuspended in 8mM IPTG solution (Gold Biotechnology #12481C100) with 
60µg/ml Carbenicillin (Gold Biotechnology #C-103-25) to achieve the final OD of 15. 
For pha-4 RNAi (bSEM 865), bacteria were resuspended with M9 only. 100ul of the 
bacterial mixture was spotted on unseeded NGM small plates (diameter of 35mm). They 
were incubated at 20°C for two days.  
 For RNAi assays, 10 L4 worms (P0) were placed on a medium OP50-seeded plate 
and cultured at 25C for 2.5 days. Their progeny (F1) at the L4 stage were first moved to 
an empty vector plate to minimize the amount of OP50 bacteria transferred to the RNAi 
plates. After allowing worms to crawl to get rid of OP50 bacteria on their cuticle, 15 F1 
L4 worms were placed on a RNAi plate and cultured at 25°C for 22-24hr. The embryos 
(F2) were moved to an OP50 seeded plate and reared at 25°C. Two days later, the number 
of worms that show wildtype phenotype (i.e. survival or fertility) was recorded. 
 
Immunohistochemistry 
Embryos were collected from plates, washed with M9 three times, and placed on a poly-
lysine coated slide. For PHA-4 antibody staining, embryos were fixed with 2% 
paraformaldehyde solution under a coverslip. The slides were incubated in a humidity 
chamber for 25 min and then placed on a metal plate on dry ice for at least 10 min. For 
DLG-1 staining, embryos were covered with a coverslip and directly placed on the metal 
plate on dry ice for more than 30 min. The coverslip was popped off to crack and 
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permeabilize embryos. Then, the slides were submersed in ice-cold methanol for 3 min 
for PHA-4 staining or 5 min for DLG-1 staining and washed twice with 1x TBST (Tris-
Buffered Saline Tween) for 5 min at room temperature. To prevent non-specific staining, 
the embryos were incubated with 50ul of TNB (0.1 M Tris–HCl, 0.15 M NaCl, 0.05% 
Tween 20, pH 7.5 containing blocking reagent (NEN)) containing 10% NGS (Normal 
goat serum; Jackson ImmunoResearch #113435) in a humidity chamber at room 
temperature for 30 min. The PHA-4 primary antibody (KALTENBACH et al. 2005) and/or 
DLG-1 antibody (Thermo #NG159845) were added to the slides, which then were placed 
in a humidity chamber and incubated at 15°C. After washed with 1x TBST three times, 
the slides were incubated with the secondary antibodies (Invitrogen) for two hours in a 
humidity chamber at room temperature. 7ul of DAPI solution (Invitrogen #S36938) was 
added to the slide and the coverslip was placed. The edge of the coverslip was sealed 
with a nail polisher. 
 
Microscopy and image processing 
Images were obtained using Zeiss LSM780 confocal microscope (a 63x PlanApo oil 
immersion lens with 2x digital zoom). Each z-stack image was 0.32µm apart. Using 
Image J, a maximum intensity projection image was obtained per embryo. Then, the 
intensity of signals in the pharyngeal cells was measured by using Volocity Image 
Analysis Software (PerkinElmer).  
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pha-4(ts) strains 
pha-4(ts) strains have a pha-4 nonsense mutant allele, either q500 or zu225, in smg-
1(cc546ts) background. pha-4(q500) and pha-4(zu225) bear nonsense mutations in aa349 
and aa384, respectively (KALTENBACH et al. 2005). Normally, pha-4(q500) and pha-
4(zu225) transcripts are rapidly degraded by the nonsense-mediated decay system, a 
process responsible for eliminating transcripts bearing nonsense mutations, and most of 
homozygous mutants show embryonic lethality (KALTENBACH et al. 2005). However, 
when the nonsense-mediated decay process is compromised, truncated but functional 
PHA-4 proteins are produced and mutants become viable (KALTENBACH et al. 2005). By 
having temperature sensitive allele of smg-1, which encodes an essential component of 
the NMD pathway, in the background of pha-4(q500) or pha-4(zu225) mutants, we can 
control the accumulation of truncated PHA-4 proteins (KALTENBACH et al. 2005). For 
instance, the NMD pathway is inactive at 24°C, thus smg-1(cc546ts); pha-4(zu225) 
animals could grow normally, whereas they show severe defects in pharynx development 
when reared at 15°C, at which the NMD pathway is rigorous and targets pha-4(zu225) 
transcripts for degradation (KALTENBACH et al. 2005; UPDIKE and MANGO 2007). At the 
intermediate temperature of 20°C, smg-1(cc546ts); pha-4(zu225) animals show some 
PHA-4 protein accumulation, but they fail to pass the first larval stage (KALTENBACH et 
al. 2005; UPDIKE and MANGO 2007). 
 
Chromatin immunoprecipitation (ChIP) 
Worms were fed with empty vector RNAi or pha-4 RNAi as described above. 
Approximately, 150,000 embryos were frozen in liquid nitrogen and thawed in ice. They 
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were fixed with 1.5% formaldehyde solution for 30 min at room temperature. Then, 
glycine (final concentration of 0.125M) was added to quench the formaldehyde. After 15 
min of incubation, embryos were carefully washed with pre-chilled M9 containing 1x 
protease three times. Fixed embryos were resuspended in nuclear lysis buffer (50mM Tris 
pH 8.0, 10 mM EDTA pH 8.0, 0.2 % SDS) containing 1x PhosStop (Roche 
#04906845001) and 1x protease. The samples were sonicated using QSonica Q700 
Sonicator with a program containing 20 cycles of 20 sec on, 20 sec off. Two steps 
preceded immunoprecipitation. First, fragmented chromatin was cleaned by incubating 
with 25µl of protein A agrose beads in 1ml of ChIP dilution buffer (0.01% SDS, 1.1% 
Triton X-100, 1.2mM EDTA, 16.7mM Tris-HCl pH 8.1, 167mM NaCl) for an hour. 
Second, 2µg of RNA polymerase II antibody (CTD4H8; Covance #MMS-128P) or 4µg 
of H3K9me3 antibody (Abcam #ab8898) was incubated with 25µl of protein G magnetic 
beads for at least 6 hours at 4°C. 45-50µg of sheared chromatin was incubated overnight 
with magnetic beads-bound RNA polymerase II antibody at 4°C. 10% of sonicated 
chromatin was also saved as an input at -20°C overnight. After incubation of antibody 
and chromatin, the protein/DNA complex was incubated with 1ml of the following 
buffers twice for 5 min on the rotator to remove any chromatin that was unbound to the 
antibody; ChIP dilution buffer, low salt buffer (0.1% SDS, 1% Triton X-100, 2mM 
EDTA, 20mM Tris-HCl pH 8.1, 150mM NaCl), high salt buffer (0.1% SDS, 1% Triton 
X-100, 2mM EDTA, 20mM Tris-HCl pH 8.1, 500mM NaCl), and LiCl buffer (EMD 
Millipore #20-156). Chromatin was lastly washed with TE buffer for three times before 
proceeding to the next step. To reverse cross-links, the antibody-chromatin mixture as 
well as input chromatin were incubated with 150µl of ChIP elution buffer (1% SDS, 
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50mM NaHCO3, 140mM NaCl) at 55°C for an hour. Then, RNAse A (0.06mg/ml) was 
added to each tube and incubated at 37°C for 30 min to degrade RNAs. Then, the 
samples were incubated with proteinase K (0.26µg/µl) at 65°C overnight. DNA recovered 
from ChIP samples and input DNA were collected by using QIAquick PCR purification 
kit (QIAGEN #28106). Purified DNA was run on a 2% agrose gel, and 100-600 bp 
fragments were isolated for further qPCR analysis. 
 
qPCR and analysis 
Quantitative PCR was performed following the instruction provided by KAPA SYBR 
FAST Universal qPCR kit (KAPA Biosystem #KK4602). For qPCR following Pol II 
ChIP, 0.01µg to 10µg genomic DNA were used to construct a standard curve. When 
cDNA was used as a template for qPCR, the expression level of F35G12.2 was used as a 
reference. At least one of the qPCR primer pair was designed to span an exon-exon 
junction to avoid amplification of genomic DNA. The sequences of the primers used in 
this study are in Appendix IV. To determine the difference in gene expression between 
wildtype and daf-12 mutants, the “delta-delta Ct method” (LIVAK and SCHMITTGEN 2001) 
was used. 
 
RNA extraction 
Young adult worms were washed off from plates and treated with the bleach solution 
(0.75% bleach containing 0.25M NaOH) to obtain early embryos. The embryos were 
snap-frozen in liquid nitrogen. To the partially thawed embryos, the same volume of 
glass beads (Sigma #G8772) and 1ml of Trizol were added. After 30 sec of vortex 
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followed by 3min of incubation at room temperature, 300µl of chloroform was added to 
the worm mixture, which was then shaken for 15 sec and incubated at room temperature 
for 3 min. The mixture was centrifuged at 14,000rpm for 15 min at 4°C, and the aqueous 
phase was transferred to a new tube. An equal volume of cold (4°C) isopropanol, 1/10 
volume of 3M sodium acetate (pH 5.5) (Calbiochem #567422), and 1ul of GlycoBlue 
(Ambion #AM9516) were added to the aqueous phase and incubated at -20°C for longer 
than 30 min. After spinning down the tubes at 14,000 rpm for 15min at 4°C, the 
supernatant was removed and the blue pallet was washed with 70% cold (-20°C) ethanol. 
The tubes were centrifuged again at 9500rpm for 5min at 4°C, and the supernatant was 
removed. The pellet was air-dried for about 5 min and dissolved in 50ul of Nuclease-free 
water. RNA purification was performed using RNA Clean & Concentrator kit (Zymo 
Research #R1015) following the protocol provided by the manufacturer. 110ng - 1ug of 
total RNA was used to synthesize cDNAs (ProtoScript First Strand cDNA Synthesis kit, 
New England BioLabs #E6300S). To avoid DNA-RNA duplex formation, which can 
impede quantitative PCR analysis, the resulting cDNAs were incubated with RNAse H 
(New England BioLabs #M0297S) at 37° for 30 min followed by incubation at 65°C for 
20 min to inactivate the enzyme. 
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Results 
DAF-12 is required for robust pha-4 RNAi 
We chose to use pha-4 RNAi to test the role of DAF-12 in RNAi. PHA-4 is the C. 
elegans orthologue of the FoxA transcription factor required for the development of 
pharynx (or foregut), the feeding organ that pumps the food into the intestine for 
digestion (HORNER et al. 1998; GAUDET and MANGO 2002; MANGO 2009). Low 
expression of pha-4 in embryos causes defects in pharynx formation, thus leading to 
larval lethality (MANGO et al. 1994). Such conspicuous pha-4 RNAi phenotypes—death 
soon after hatching—allowed us to track changes in the pha-4 RNAi efficiency.  
To sensitize the RNAi assay, we diluted pha-4 dsRNA-expressing bacteria with 
different amounts of neutral bacteria (Fig. 2.1). This assay allowed us to detect any subtle 
differences between wildtype and daf-12(rh61rh411; null) mutants in the severity of the 
pha-4 RNAi phenotype, which could be otherwise masked when a high dose of dsRNA is 
provided (TIMMONS et al. 2003; HABIG et al. 2008; ZHUANG and HUNTER 2011). When 
wildtype and daf-12 mutants were exposed to a range of dsRNA targeting pha-4, we 
found that daf-12 mutants had better viability than wildtype animals, typically two to 
three fold (Fig. 2.2).  
As another way of determining a low RNAi efficiency in daf-12 mutants, we 
examined PHA-4 protein in embryos after strong pha-4 RNAi. Consistent with the weak 
pha-4(RNAi)-associated lethality in daf-12 mutants, PHA-4 accumulation was two fold 
higher in daf-12 mutants than in wildtype embryos (Fig. 2.3). This observation supports 
the conclusion that DAF-12 is required for robust pha-4 RNAi, and implies that DAF-12 
modulation occurs prior to or during mid-embryogenesis.  
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Figure 2.1. A schematic diagram of the pha-4 RNAi assay used for this study.  
10-15 wildtype (black) and daf-12 mutants (red) (P0) at the fourth larval stage (L4) were 
fed for 24hr with pha-4 dsRNA-expressing bacteria mixed with control (empty vector) 
RNAi bacteria. We made various dilutions of pha-4 dsRNA-expressing bacteria (less 
diluted, thus strong pha-4 RNAi (A); highly diluted, thus weak pha-4 RNAi (B)) to 
sensitize the assay. Embryos (F1) were moved to the plates seeded with normal OP50 
E.coli food and the viability of F1 was scored. 
  
! 32!
 
 
 
 
 
 
 
 
 
Figure 2.2. DAF-12 is required for robust pha-4 RNAi.  
WT and daf-12(rh61rh411; null) mutants (P0) were fed with pha-4 dsRNA-expressing 
bacteria diluted with different amounts of mCherry (neutral) dsRNA-expressing bacteria. 
The fraction of progeny (F1) that grew to adulthood was scored. n=4. Error bars represent 
standard deviation. 
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Figure 2.3. PHA-4 accumulation was higher in daf-12 mutants than in wildtype 
when treated with pha-4 RNAi.  
(A) Embryos of animals treated with EV (control; empty vector) or pha-4 RNAi were 
collected and subjected to immunochemistry. Embryos at the 1.5 fold stage (mid-
embryogenesis) were imaged for quantification. Normally, PHA-4 is expressed strongly 
in pharyngeal cells (P) and weakly in the intestine (I) at this stage of embryogenesis. 
Asterisks denote the rectal cells, which express pha-4 regardless of pha-4 RNAi. (B) 
PHA-4 in the anterior region of embryos was quantified as described in Materials and 
Methods. n=3. Student t-test was used for the analysis. a.u, arbitrary unit. 
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Figure 2.3 (continued). PHA-4 accumulation was higher in daf-12 mutants than in 
wildtype when treated with pha-4 RNAi.  
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How could DAF-12 increase the efficiency of pha-4 RNAi? One possible 
explanation is that DAF-12 modulates the RNAi process and enhances the silencing 
efficiency. Another possibility is that DAF-12 acts as a suppressor of pha-4 itself. In the 
latter case, the repression on pha-4 would be lifted in daf-12 mutants, and as a 
consequence, pha-4 RNAi would appear less efficient due to a higher baseline of pha-4 
expression or activity in daf-12 mutants. To differentiate between these two possibilities, 
we decided to determine whether DAF-12 regulates the lethality caused by pha-4 partial 
loss-of-function mutations. If DAF-12 were a novel pha-4 suppressor, lack of functional 
DAF-12 should increase the expression or the activity of PHA-4, thus restoring 
pharyngeal development in pha-4 mutants. Alternatively, daf-12 might only repress loss 
of function of pha-4 achieved by RNAi. We found the later scenario to be true: a daf-12 
null mutation failed to restore PHA-4 protein in embryos harboring a pha-4(q500) partial 
loss-of-function mutation (Fig. 2.4A). Moreover, a daf-12 mutation did not rescue the 
pharyngeal defects of pha-4(ts) mutants (KALTENBACH et al. 2005; UPDIKE and MANGO 
2007) that were reared at semi-permissive temperature (Fig. 2.4B). The same result was 
obtained using a weaker pha-4 partial loss-of-function allele, zu225 (Fig. 2.5) 
(KALTENBACH et al. 2005). These results indicate that a weak pha-4 RNAi phenotype in 
daf-12 mutants is likely due to reduced activity of the RNAi process in the daf-12 
mutants, and not to modulation of pha-4 itself.  
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Figure 2.4. pha-4(q500)-associated larval lethality and low PHA-4 accumulation 
were not suppressed by a daf-12 null mutation.  
(A) pha-4(q500) and pha-4(q500); daf-12(rh61rh411) embryos were stained with PHA-4 
and DLG-1 antibodies. DLG-1/Discs Large proteins are localized to the apical-
basolateral boundary of epithelial cells, including pharyngeal and intestinal cells 
(BOSSINGER et al. 2001; FIRESTEIN and RONGO 2001). mut, the embryos homozygous for 
pha-4(q500); wt, the embryos whose genotypes were either pha-4(q500)/+ and +/+. (B) 
Previous studies reported that smg-1(cc546ts); pha-4(q500) incubated at 20°C from 
embryogenesis are arrested at the first larval stage (L1) (KALTENBACH et al. 2005; 
UPDIKE and MANGO 2007). The embryonic and larval lethality of progeny of smg-
1(cc546ts); pha-4(q500) and smg-1(cc546ts); pha-4(q500); daf-12(rh61rh411) incubated 
at 20°C was compared. n=2. 
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Figure 2.4 (continued). pha-4(q500)-associated larval lethality and low PHA-4 
accumulation were not suppressed by a daf-12 null mutation.  
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Figure 2.5. daf-12 RNAi and a daf-12 null mutation failed to rescue pha-4(zu225)-
associated lethality.  
(A) When cultured at 25°C, daf-7(e1372) animals became dauers, whereas daf-12 RNAi 
inhibited the dauer-constitutive phenotype of daf-7(e1372) animals. This result showed 
that daf-12 RNAi we used for the study was functional. EV RNAi, empty vector (control) 
RNAi. (B) smg-1(cc546ts); pha-4(zu225) were fed with GFP RNAi (negative control), 
smg-8 (positive control) (ROSAINS 2012), and daf-12 RNAi food and cultured at 20°C, 
where the strains normally fail to form pharynx due to insufficient accumulation of PHA-
4 proteins and die after hatching (KALTENBACH et al. 2005; UPDIKE and MANGO 2007). 
Error bars represent standard deviation. n=2. (C) A triple mutant smg-1(cc546ts); eri-
8(tm1860) pha-4(zu225) was constructed to increase the RNAi efficiency. The 
pharyngeal phenotypes of the triple mutants treated with either EV RNAi or daf-12 RNAi 
were observed. Defects in pharynx further scored include pharynx unattached to the 
mouth, pharynx unattached to the intestine and no pharynx structure. (D) Pharynx 
phenotypes (normal pharynx, Pun (pharynx unattached to the mouth), and no pharynx) of 
triple mutant larvae, smg-1(cc546ts); pha-4(zu225); daf-12(rh61rh411), reared at 19°C, 
20°C and 21°C were observed. More than 80 larvae were examined except for the 
experiments at 19°C (28 larvae observed). n=1 for each temperature. (E) Although smg-
1(cc546ts); pha-4(zu225); daf-12(rh61rh411) that were reared at 21°C did not show any 
severe defects in pharynx, they failed to pass the first larval stage, whereas smg-
1(cc546ts); pha-4(zu225) grew to adulthood. Asterisks mark the mothers that were 
maintained at the permissive temperature (24°C) and produced progeny at 21°C. 
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Figure 2.5 (continued). daf-12 RNAi and a daf-12 null mutation failed to rescue pha-
4(zu225)-associated lethality. 
  
0 
20 
40 
60 
80 
100 
GFP smg-8 daf-12 V
ia
bi
lit
y 
of
 s
m
g-
1(
cc
54
6t
s)
; 
ph
a-
4(
zu
22
5)
 (%
) 
RNAi 
! 40!
C               EV RNAi       daf-12 RNAi 
  
 
 
 
D 
 
 
Figure 2.5 (continued). daf-12 RNAi and a daf-12 null mutation failed to rescue pha-
4(zu225)-associated lethality.  
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Figure 2.5 (continued). daf-12 RNAi and a daf-12 null mutation failed to rescue pha-
4(zu225)-associated lethality.  
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The role of DAF-12 in pha-4 RNAi regulation is distinct from that in the dauer 
pathway and heterochronic pathway. 
DAF-12 is known for its role in developmental timing (ANTEBI et al. 1998; BETHKE et al. 
2009; HAMMELL et al. 2009). Once hatched, C. elegans undergo four larval stages (L1 to 
L4) and become adults. Defects in the heterochronic pathway, which controls temporal 
development, lead to abnormal phenotypes in stage-specific processes. DAF-12 is 
essential for entry into dauer, an alternative larval stage where worms cease to undergo 
normal development and become resistant to environmental insults (CASSADA and 
RUSSELL 1975; FIELENBACH and ANTEBI 2008).  
Depending on the positions of the molecular lesions, different daf-12 mutants 
show distinct dauer phenotypes and heterochronic phenotypes (Table 2.1). Antebi and his 
colleagues have extensively characterized various daf-12 mutants and grouped them into 
six different classes based on their dauer and heterochronic phenotypes (Table 2.1) 
(ANTEBI et al. 1998, 2000).  For instance, the daf-12 null mutants that were tested for 
pha-4 RNAi repression (Fig. 2.2) were defective in dauer formation even in a harsh 
environment, but exhibited no particular heterochronic phenotype (ANTEBI et al. 1998). 
daf-12(rh61) mutants typically do not become dauer larvae, but show strong 
heterochronic phenotypes (ANTEBI et al. 1998). daf-12 alleles in class 6 are unique in that 
the mutants become dauers constitutively (ANTEBI et al. 2000). We took advantage of 
these comprehensive descriptions of available daf-12 mutants and asked whether a 
reduction in the pha-4 RNAi efficiency in daf-12 mutants tracked with either the dauer or 
heterochronic phenotype. Except for daf-12(rh173) mutants, which did not produce 
enough embryos for analysis, daf-12 mutants from each class showed higher viability 
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Table 2.1. daf-12 mutants with different dauer and heterochronic phenotypes. 
Modified from Antebi et al. (2000).  
 
     
Heterochronic 
phenotype 
Class 
The allele 
used for the 
pha-4 
RNAi Mutation Location 
Dauer 
phenotype 
Extra 
seam 
cellsa 
Gonadal 
migration 
defectsb 
1 rh257 
Y699 
splice 
acceptor 
LBD Defective 67%-100% 67%-100% 
2 rh62rh157 S70stop, R564C 
Before 
DBD, 
LBD 
Defective 67%-100% 0% 
3 rh61rh411 L147stop, Q618stop 
DBD,  
LBD Defective 0% 0% 
4 rh193 G582K LBD Normal 34%-66% 34%-66% 
5 rh284 P746S LBD Normal 0% 67%-100% 
6 rh274 R564C LBD Constitutive 0% 67%-100% 
 
a Seam cells (or lateral hypodermal cells) undergo cell divisions at the L2, L3, and L4 
stages and become terminally differentiated (SULSTON et al. 1983; KIPREOS 2005). 
Defects in larval developmental timing results in production of fewer or extra seam cells. 
b Normally, the gonad arms that have extended along the ventral muscle turn dorsally at 
the mid-L3 stage (HEDGECOCK et al. 1987). 
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than wildtype animals when treated with pha-4 RNAi (Fig. 2.6). This result suggests that 
the effect of DAF-12 on robust silencing induced by RNAi is separable from the function 
of DAF-12 in dauer formation and developmental timing.  
 To uncouple the role of DAF-12 in pha-4 RNAi regulation from dauer formation, 
we also tested whether the insulin-like pathway regulates pha-4 RNAi efficiency. The 
insulin-like pathway is one of the environmental sensing pathways in C. elegans, and low 
activity of insulin signaling leads to constitutive dauer formation (GOTTLIEB and RUVKUN 
1994; MALONE and THOMAS 1994; KIMURA et al. 1997; HU 2007). Two lines of evidence 
suggest that the insulin pathway does not affect pha-4 RNAi efficiency. A previous work 
in the Mango lab showed that worms carrying a mutation in daf-2 (Insulin/IGF receptor), 
which are arrested as dauers constitutively, are as sensitive to pha-4 RNAi as wildtype 
animals (SHEAFFER et al. 2008). We also found that DAF-16/FOXO, a crucial 
downstream forkhead transcription factor in insulin-like pathway, did not alter pha-4 
RNAi sensitivity (Fig. 2.7). Together, these findings indicate that the pha-4 RNAi 
efficiency is distinct from dauer-inducing pathways. 
 
The effect of DAF-12 on pha-4 RNAi enhancement depends on ligands 
One of the common characteristics of nuclear hormone receptors is that they activate 
transcription in a ligand-dependent manner. The activity of DAF-12 is also dependent on 
its ligands, dafachronic acids (DA) (MOTOLA et al. 2006; MAHANTI et al. 2014). Dietary 
cholesterol is serially oxidized to DA, and this process requires a complex network of 
enzymes (MAHANTI et al. 2014). NHR-8, another nuclear hormone receptor in C. 
elegans, activates the expression of daf-36/Rieske oxygenase, which catalyzes the first  
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Figure 2.6. Animals bearing different types of mutations in daf-12 all exhibited weak 
pha-4 RNAi phenotypes.  
The viabilities of different daf-12 mutants (Table 2.1) were normalized to that of 
wildtype. n=2. Error bars represent standard deviation. 
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Figure 2.7. DAF-16 does not regulate the efficiency of pha-4 RNAi.  
Wildtype animals and daf-16(mu86) worms were fed with pha-4 dsRNA-expressing 
bacteria from the L4 stage and the viability of their embryos were examined. n=3. Error 
bars represent standard deviation. 
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step of DA biosynthesis (MAGNER et al. 2013). Thus, nhr-8 mutants exhibit the 
phenotypes associated with a low level (but not a complete loss) of DA when cultivated 
at an elevated temperature or without a cholesterol supplement (MAGNER et al. 2013). 
When treated with pha-4 RNAi, only 6.8% of nhr-8 mutants were viable, whereas 33.5% 
of wildtype worms grew to adulthood, indicating that pha-4 RNAi was stronger when 
NHR-8 was inactivated and DA levels were low (Fig. 2.8). However, the viability of the 
double mutant, nhr-8(ok186); daf-12(rh61rh411), was reversed to 48.2% ± 10.8, which 
was virtually as high as that of daf-12 single mutants (65.5% ± 14.0) (Fig. 2.8). This 
epistasis analysis suggests that a high level of unliganded DAF-12 can enhance pha-4 
RNAi. 
The exacerbated pha-4 RNAi phenotype in nhr-8 mutants raised the question of 
whether DIN-1, which is the co-repressor of DAF-12 and competes with DA to bind to 
DAF-12 (MOTOLA et al. 2006), would be involved in pha-4 RNAi-mediated silencing. 
Like daf-12 mutants, din-1 mutants were more viable than wildtype when treated with 
pha-4 RNAi (Fig. 2.9), which implies that DIN-1 is also required for robust pha-4 RNAi. 
Overall, these findings demonstrate that in wildtype animals, a high concentration of 
unliganded DAF-12 or DAF-12 bound to DIN-1 strengthens silencing triggered by RNAi. 
We showed above that, regardless of the nature of mutation, various daf-12 
mutants were highly viable after pha-4 RNAi. Except DAF-12(rh61), which is known to 
bind to DIN-1 weakly than wildtype DAF-12 (LUDEWIG et al. 2004), the extent to which 
mutations alter the affinity to DA and/or DIN is not know yet. Based on our observation 
that DIN-1 is required for robust RNAi, it is plausible that daf-12 mutations lead to a  
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Figure 2.8. daf-12 is epistatic to nhr-8 in the pha-4 RNAi regulation.  
Animals at the L4 stage were treated with pha-4 RNAi and the numbers of their progeny 
that passed the L1 stage were scored. The viability of each mutant was normalized to that 
of wildtype. Student t-test shows that the viability of daf-12 mutants was not significantly 
different from that of nhr-8; daf-12. n=4. Error bars represent standard deviation. 
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Figure 2.9. pha-4 (RNAi)-associated lethality was repressed in din-1(dh149) mutants.  
N2 (wildtype) and din-1(dh149) animals were treated with pha-4 RNAi, and the fractions 
of their progeny that grew to adulthood were scored. The dotted line with the slope of one 
is superimposed to the graph to help the comparison between the viabilities of N2 and 
din-1 mutants. n=4.  
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slight decrease in the affinity to DIN-1, which results in low RNAi efficiency in daf-12 
mutants. 
 
DAF-12 promotes a decrease in Pol II occupancy at the locus targeted by RNAi  
How could DAF-12 regulate the robustness of RNAi? DAF-12 could increase the 
efficiency of post-transcriptional silencing induced by RNAi. Alternatively, DAF-12 
might strengthen RNAi-triggered transcriptional inactivation, a process recently 
discovered and that depends on NRDE (Nuclear RNAi-defective) factors (GUANG et al. 
2008). In C. elegans, siRNAs are incorporated into the nuclear argonaute NRDE-3, which 
localizes to the nucleus and recruits other nuclear proteins to stall RNA polymerase II 
during transcriptional elongation of the targeted gene (GUANG et al. 2010; BURKHART et 
al. 2011). Of note, the NRDE pathway is essential for RNAi targeting only a subset of 
genes (GUANG et al. 2008), indicating that transcriptional silencing is not universally 
required for RNAi-induced silencing. 
To determine whether DAF-12 prevents a change in the level of Pol II bound to 
the target gene upon RNAi, we obtained a pool of mixed-stage embryos (Fig. 2.10A) 
from pha-4 RNAi-treated worms and performed Pol II chromatin immunoprecipitation 
(ChIP) followed by qPCR. We found that wildtype and daf-12 null mutants have different 
patterns of Pol II occupancy at pha-4 in response to pha-4 RNAi (Fig. 2.10D and E). In 
wildtype embryos, Pol II enrichment at the pha-4 locus decreased by half throughout the 
gene body after pha-4 RNAi (Fig. 2.10D and E), indicating that transcriptional initiation, 
not just elongation, was inhibited. In contrast to wildtype, daf-12 mutants failed to show a  
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Figure 2.10. DAF-12 is required for transcriptional repression of pha-4 induced by 
RNAi.  
(A) Distribution of stages of embryos used for chromatin immunoprecipitation (ChIP) 
Wildtype (WT) and daf-12 mutants were treated with EV (empty vector; control) RNAi 
or pha-4 RNAi and then mixed stages of their embryos were subjected to ChIP. More 
than 140 embryos were observed for each strain and each RNAi treatment. (B) pha-4 
gene structure. Grey boxes represent eight exons of pha-4. The sites amplified by qPCR 
primers are indicated by red bars. The blue line denotes the region targeted by pha-4 
dsRNA. (C, D and E) qPCR analysis of Pol II ChIP at four different regions of pha-4 
(indicated by red bars in (A)) in wildtype and daf-12 mutants. As a negative control, we 
also measured Pol II enrichment at srw-99 (C), which encodes a serpentine receptor. We 
used two positive controls, eft-3, a housekeeping gene encoding a translation elongation 
factor, and elp-1, a gene located 5kb downstream of pha-4 and encodes a microtubule-
interacting protein (C). Pol II enrichment at the pha-4 locus and control genes was 
calculated relative to input DNA (% input). Then, % input at pha-4 was rescaled using 
Pol II enrichment at srw-99 and eft-3 (D) or elp-1 (E) as 0 and 1, respectively. The ratio 
of Pol II occupancy after pha-4 RNAi to EV RNAi treatment is shown. n=3. Error bars 
represent standard deviation.  
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Figure 2.10 (continued). DAF-12 is required for transcriptional repression of pha-4 
induced by RNAi. 
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D. Normalized to eft-3 and srw-99                
 
 
E. Normalized to elp-1 and srw-99
 
 
Figure 2.10 (continued). DAF-12 is required for transcriptional repression of pha-4 
induced by RNAi.  
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significant reduction in Pol II enrichment (Fig. 2.10D and E). Instead, Pol II occupancy at 
the pha-4 locus in daf-12 mutants increased when treated with pha-4 RNAi (Fig. 2.10D 
and E). These results suggest that lack of RNAi-induced transcriptional repression in daf-
12 mutants is associated with their low RNAi efficiency. We used two different reference 
genes (eft-3 and elp-1) to normalize Pol II and the analyses produced the same trends, 
although the absolute values varied (Fig. 2.10D and E). Together, our Pol II-qPCR 
experiments revealed the association between increased Pol II occupancy and low 
silencing activity in daf-12 mutants.   
In addition to inhibition of transcription, RNAi promotes the enrichment of 
H3K9me3 at targeted loci (GUANG et al. 2010; BURTON et al. 2011; BUCKLEY et al. 
2012; GU et al. 2012), a histone modification related to inactive transcription (VAKOC et 
al. 2005; BARSKI et al. 2007; MIKKELSEN et al. 2007; KIM et al. 2007; REGHA et al. 
2007; ROSENFELD et al. 2009; BLACK and WHETSTINE 2011). Using H3K9me3 ChIP-
qPCR, we asked whether the levels of H3K9me3 at the pha-4 locus differ in wildtype 
versus daf-12 mutants after pha-4 RNAi. Unlike the distinct patterns of Pol II enrichment 
at the pha-4 locus in wildtype and daf-12 mutants, both strains showed a two-fold 
increase in H3K9me3 at the pha-4 coding region (Fig. 2.11). This result derived from a 
single experiment and more experiments are required to draw any solid conclusion. 
However, if this pattern is reproducible, it would indicate that DAF-12 does not affect the 
accumulation of H3K9me3 in response to RNAi. In addition, it would suggest that DAF-
12 could adjust Pol II loading independently of H3K9me3. 
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Figure 2.11. DAF-12 is not required for the H3K9me3 enrichment at the pha-4 locus 
after pha-4 RNAi.  
H3K9me3, a histone modification associated with inactive transcription, is involved in 
maintenance of the silenced state induced by RNAi (BURTON et al. 2011; BUCKLEY et al. 
2012; GU et al. 2012). Mixed stages of embryos of animals treated with empty vector 
(EV; control) RNAi and pha-4 RNAi treatment were subjected to H3K9me3 chromatin 
immunopreciptation (ChIP). qPCR primers were designed to target pha-4 promoter 
region (200bp upstream of the first ATG) (A) and pha-4 exon 7 and intron 7 junction (B). 
% input values at the pha-4 locus were normalized to H3K9me3 enrichment at pcaf-1. 
n=1. 
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DAF-12 acts in mothers to enhance the RNAi efficiency in zygotes 
The NRDE pathway is more critical for RNAi-mediated silencing in progeny than P0 
parents. As explained above, in our typical experiment, we initiated RNAi in 
hermaphrodites (P0) at the fourth (last) larval stage and examined RNAi phenotypes in 
embryos (F1). The effect of daf-12 on RNA pol II accumulation raised the question of 
whether DAF-12 boosted the RNAi efficiency in the P0 animals that were directly 
exposed to dsRNA or functioned mostly in embryos to trigger transcriptional regulation, 
similar to NRDE-3.  
To determine whether DAF-12 acted in dsRNA-exposed animals (P0) or their 
zygotes (F1), we fed daf-12/+ heterozygous animals (P0) with pha-4 RNAi and tested 
whether the pha-4 RNAi lethality of the F1 depended on the genotype of mothers or 
zygotes (F1). daf-12 homozygous embryos (F1) from heterozygous animals (P0) 
displayed as strong a pha-4 RNAi response as their wildtype siblings (Fig. 2.12). This 
result suggests that DAF-12 functions in P0 mothers, and that a wildtype copy of daf-12 
in the P0 was able to induce robust pha-4 RNAi in zygotes. In this experiment, we used 
hermaphrodites, which can produce both sperm and oocytes. To test whether DAF-12 
acted in mothers or fathers, we established crosses between wildtype parents and daf-12 
mutants, which revealed that DAF-12 was required in mothers to regulate pha-4 RNAi in 
zygotes (Fig. 2.13). Together, these results indicate that functional DAF-12 in mothers is 
necessary and sufficient to enhance RNAi efficiency in zygotes.  
 If DAF-12 acts in the animals (P0) that are directly exposed to dsRNA-expressing 
bacteria, we reasoned that DAF-12 may be required for robust pha-4 RNAi in the P0 as 
well. Low expression or activity of pha-4 during larval development leads to defects in  
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Figure 2.12. The genotype of parents, not zygotes, determines the severity of pha-4 
RNAi phenotypes in zygotes.  
Animals with two copies of daf-12 (WT), heterozygous for daf-12 null mutation (daf-
12/+) or homozygous for daf-12 null mutation (daf-12) were treated with pha-4 RNAi. 
The genotypes of the progeny of daf-12 heterozygous animals were confirmed by PCR. 
Student t test indicates that wildtype and daf-12 homozygous mutant siblings from 
heterozygous hermaphrodites were not significantly different in pha-4(RNAi)-associated 
lethality. n=3. Error bars represent standard deviation. 
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Figure 2.13. DAF-12 functions in mothers to enhance pha-4(RNAi) lethality in 
zygotes.  
(A) Three pharynx phenotypes (normal, Pun and no pharynx) were scored to test the 
parental vs. maternal effect of DAF-12. Antibody staining for DLG-1/Disc large, which 
is localized to adherence junctions (BOSSINGER et al. 2001; FIRESTEIN and RONGO 2001), 
allowed us to better observe pharyngeal defects. mCherry expression indicated that the 
embryos were cross-progeny, not self-progeny. Asterisks denote the mouths of embryos. 
Yellow bar marks the pharyngeal-intestinal valve. (B) The daf-12 null mutation from 
mothers was sufficient to rescue severe pharyngeal defects caused by pha-4 RNAi in daf-
12 heterozygous progeny. The numbers in parentheses are the numbers of embryos 
examined for pharyngeal defects. Herma., hermaphrodites. n=3. 
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Figure 2.13 (continued). DAF-12 functions in mothers to enhance pha-4(RNAi) 
lethality in zygotes.  
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gonad development and sterility (Fig. 2.14A) (UPDIKE and MANGO 2007; CHEN and 
RIDDLE 2008). P0 daf-12 mutants that were exposed to pha-4 RNAi from the first larval 
stage were as susceptible to pha-4 RNAi as wildtype larvae (Fig. 2.14B), indicating that 
DAF-12 was dispensable for robust RNAi in P0 animals that were directly exposed to 
dsRNA. In summary, DAF-12 does not affect the RNAi efficiency in P0 mothers, but it is 
required for strong silencing in offspring. These observations demonstrate that unlike 
many regulators of RNAi, DAF-12 is involved in the transmission of silencing signals 
from mothers to zygotes.  
  
The effect of DAF-12 on the RNAi enhancement depends on the population density 
during mother’s larval development 
A remarkable feature of DAF-12 is that its activity is determined by the quality of the 
environment; in a favorable environment, DAF-12 promotes reproductive growth, 
whereas harsh conditions result in a decrease in the level of DA, and unliganded DAF-12 
promotes entry into dauer (NOLAN et al. 2002; GERISCH and ANTEBI 2004; FIELENBACH 
and ANTEBI 2008; HAMMELL et al. 2009). Thus, we investigated the contribution of the 
parental environment to DAF-12-mediated RNAi enhancement in zygotes. Our choice of 
the environmental input was high population density, which is known to induce dauer 
formation (GOLDEN and RIDDLE 1982). C. elegans produces and continuously secretes 
pheromones, and its concentration is indicative of population density (GOLDEN and 
RIDDLE 1984; BUTCHER et al. 2009). Overcrowding or a high level of pheromone 
dampens the biosynthesis of DA, and animals are committed to the dauer stage instead of  
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Figure 2.14. daf-12 mutants are as susceptible to pha-4 RNAi as wildtype (WT) 
during larval growth.  
(A) pha-4 RNAi during larval development cause defects in gonad development and 
leads to sterility (UPDIKE and MANGO 2007; CHEN and RIDDLE 2008). (B) Wildtype and 
daf-12(rh61rh411) worms were fed with pha-4 dsRNA-expressing bacteria throughout 
larval development and their germ lines were examined when they became adults. The 
numbers in parentheses are the numbers of gonad arms examined for germ line defects. 
n=3. 
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Figure 2.14 (continued). daf-12 mutants are as susceptible to pha-4 RNAi as 
wildtype (WT) during larval growth.  
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reproductive development (GOLDEN and RIDDLE 1982; SCHACKWITZ et al. 1996; 
SCHAEDEL et al. 2012). We cultivated wildtype and daf-12 mutants under crowded 
(~1500 worms) versus sparse (~60 worms) conditions during their larval development 
and then treated the same number of worms from each condition with pha-4 RNAi (Fig. 
2.15A). Worms were never starved or became dauers during the procedure. Strikingly, 
we found that when mothers developed in a low-population condition and were treated 
with pha-4 RNAi, the viability of daf-12 mutants was 2.5 fold higher than that of 
wildtype (Fig. 2.15B), similar to what we observed previously. In contrast, the strong 
RNAi phenotype was restored in daf-12 mutant embryos when their mothers were 
cultivated under the crowded condition (Fig. 2.15B). These results suggest that the 
function of DAF-12 in RNAi depends on the environmental context; normally, when 
mothers sense a relatively low concentration of pheromone, maternal DAF-12 is required 
to ensure robust silencing in zygotes induced by RNAi. If mothers are exposed to a high 
dose of pheromone, DAF-12 becomes dispensable, and RNAi in zygotes remains robust 
by an unknown pathway. Of note, we found that daf-12 mutants show a low RNAi 
response regardless of growth temperatures (20°C versus 25°C) (Fig. 2.16), implying that 
not all environmental conditions affect the dependency on DAF-12 in RNAi. 
 What pathways could mediate the environmental effect on RNAi? Based on the 
previous findings that the TGF-β pathway is regulated by environmental cues (REN et al. 
1996; SCHACKWITZ et al. 1996), we examined the efficiency of pha-4 RNAi for TGF-β 
pathway mutants (Fig. 2.17A). A mutation in daf-4, which encodes a type II TGF- β 
receptor, enhanced pha-4 RNAi, whereas a mutation in daf-3, whose protein products act  
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Figure 2.15. The role of DAF-12 in RNAi depends on the environmental context 
during the larval development of mothers.  
(A) A schematic diagram of the experimental design for testing the environmental 
contribution to RNAi. Wildtype and daf-12 mutant animals were hatched and grew on 
either an under-crowded plate (Few; ~60 animals) or an over-crowded plate (Many; 
~1500 animals). Food was added to the populated plates during the experiment so that 
worms were never starved. Then, animals at the fourth larval stage (L4) were treated pha-
4 RNAi under the same environment (15 worms/pha-4 RNAi). The number of their 
progeny that grew to adulthood was scored. (B) The viability of animals was normalized 
to that of “few” WT. WT, wildtype; daf-12 mut, daf-12(rh61rh411). The dotted grey line 
indicates the wildtype level viability, which is one. Solid gray lines represent the average 
values. n=4. 
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Figure 2.15 (continued). The role of DAF-12 in RNAi depends on the environmental 
context during the larval development of mothers.  
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Figure 2.15 (continued). The role of DAF-12 in RNAi depends on the environmental 
context during the larval development of mothers. 
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Figure 2.16. The effect of DAF-12 in RNAi enhancement does not depend on the 
growth temperature.  
Wildtype (WT) and daf-12 mutants hatched and grew at either 20°C or 25°C.  When the 
animals reached the L4 stage, they were treated with pha-4 RNAi at 25°C. The numbers 
of progeny that grew to adulthood were scored. n=3. Error bars represent standard 
deviation. 
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as a negative regulator of the TGF-β dauer pathway, repressed pha-4 RNAi (Fig. 2.17B). 
We note here that all the mutants used for these assays were not backcrossed, therefore it 
is possible that the alteration in pha-4 RNAi efficiency is due to some background 
mutations. Moreover, since the mutants were tested only with pha-4 RNAi, it is not yet 
clear whether the TGF-β dauer pathway regulates RNAi in general or not. Nevertheless, 
the direction of enhancement and repression by daf-4 and daf-3 respectively is consistent 
with the notion that this pathway could mediate the environmental cues.  
Among the mutants that showed changes in the efficiency of pha-4 RNAi, daf-4 
mutants exhibited the strongest enhancement (Fig. 2.17B). daf-4 mutants form dauer 
larvae constitutively (Daf-c) (GOLDEN and RIDDLE 1984) and the dauer phenotype is 
suppressed by daf-12 mutations, indicating daf-12 is downstream of daf-4 in dauer 
pathway. However, our epistasis analysis revealed that daf-4 was epistatic to daf-12 in 
pha-4 RNAi regulation (Fig. 2.18). Daf-c phenotype of daf-4 mutants suggests that the 
animals activate mechanisms responding to unfavorable environments. Both populous 
conditions and the daf-4 mutation induced strong pha-4 RNAi response without DAF-12, 
which strengthens the argument that environmental conditions influence RNAi 
robustness. Whether DAF-4 mediates the environmental effect on RNAi remains to be 
seen, but this novel epistatic interaction between daf-4 and daf-12 may lead to 
identification of new mechanisms that elicit physiological responses to the environment. 
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Figure 2.17. Some mutants in the TGF-beta dauer pathway enhance or mitigate 
pha-4 RNAi phenotype.  
(A) TGF-beta dauer pathway in C. elegans (modified from (FIELENBACH and ANTEBI 
2008)). (B) Various mutants in the TGF-beta dauer pathway were treated with pha-4 
RNAi and viabilities of their embryos were normalized to that of wildtype. n=3 for each 
mutant. 
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Figure 2.17 (continued). Some mutants in the TGF-beta dauer pathway enhance or 
mitigate pha-4 RNAi phenotype. 
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Figure 2.18. daf-4 is epistatic to daf-12 in pha-4 RNAi regulation. 
pha-4 RNAi causes lethality. Animals were treated with pha-4 RNAi and the number of 
their progeny passed the first larval stage was scored. Error bars represent standard 
deviation. n=3. Error bars represent standard deviation. 
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The effect of DAF-12 on RNAi is not solely dependent on the NRDE pathway 
How could DAF-12 in mothers ensure robust RNAi in zygotes? Independent microarray 
studies suggest that daf-12 transcripts are not deposited in early embryos (BAUGH et al. 
2003; REINKE et al. 2003; YUZYUK et al. 2009; LEVIN et al. 2012). Therefore, it is less 
likely that maternal DAF-12 protein is deposited in zygotes and establishes RNAi-
triggered silencing. An alternative mechanism could be that DAF-12 in mothers regulates 
the maternal contribution of RNAi machinery components to zygotes. We decided to test 
a potential interaction between DAF-12 and the NRDE pathway, which is required to 
maintain RNAi silencing in the progeny of dsRNA-exposed animals (GUANG et al. 2008, 
2010), First, we first asked whether the NRDE pathway and DAF-12 are required to 
silence the same cohort of genes. The NRDE pathway does not affect all RNAi, but 
selectively targets transcripts that are localized in nuclei (GUANG et al. 2008). These are 
mRNAs that may take longer to become spliced or to transit from the nucleus to the 
cytoplasm. We fed daf-12 mutants and nrde-3 mutants with various dsRNA-expressing 
food and compared the severity of their RNAi phenotypes with that appearing in wildtype 
animals (Table 2.2). Both daf-12 and nrde-3 are required for strong response to pha-4 
RNAi, lin-26 RNAi, and par-1 RNAi (Table 2.2, Fig. 2.19 and Fig. 2.20) (ZHUANG et al. 
2013), suggesting that DAF-12 and NRDE-3 are required to silence these genes robustly. 
Of note, the degree of the NRDE-3 effect was significantly greater than that of DAF-12. 
For instance, when pha-4 RNAi was strong enough to cause 100% lethality in wildtype 
embryos, 82.65% of nrde-3 mutants were viable, whereas the viability of daf-12 mutants 
was only 3.25%. On the other hand, when fed with bacteria expressing skn-1, pos-1, or 
pal-1 dsRNA, neither DAF-12 nor NRDE-3 altered the efficiency of silencing   
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Table 2.2. RNAi phenotypes of some genes are enhanced or repressed in daf-12 and 
nrde-3 mutants.  
Wildtype, daf-12 mutants, and nrde-3 mutants were fed with dsRNA targeting genes 
listed below. Repression (Rep)/enhancement (Enh) indicate equal or greater than 1.5 fold 
change in RNAi phenotype of the mutants compared to wildtype. NT, Not tested. NSD, 
No significant difference. *Tested by (ZHUANG et al. 2013). **Tested by (GUANG et al. 
2008). 
 
  
RNAi target gene RNAi phenotype compared to wildtype 
Name Identity Role 
Nuclear 
lamina 
enrichment 
RNAi 
phenotype 
daf-12 
(rh61rh411) 
nrde-3 
(gg066) 
pha-4 
FoxA 
transcription 
factor 
Pharynx development. 
Diet-restriction induced 
longevity 
High Emb. lethality Rep Rep 
lin-26 Zinc-finger protein 
Differentiation of non-
neuronal ectodermal 
cells and the somatic 
gonad epithelium 
Low Emb. lethality Rep Rep 
par-1 
serine-
threonine 
kinase 
Embryonic polarity Low Emb. lethality Rep Rep* 
F33H2.5 Unknown Function unknown. Maternal effect gene High 
Emb. 
lethality Rep NT 
mex-3 
RNA 
binding 
protein 
AB and P3 blastomere 
specification High 
Emb. 
lethality Enh NT 
skn-1 
bZip 
transcription 
factor 
EMS blastomere 
specification. Low 
Emb. 
lethality NSD NSD 
! 74!
Table 2.2 (continued). RNAi phenotypes of some genes are enhanced or repressed in 
daf-12 and nrde-3 mutants 
  
RNAi target gene RNAi phenotype compared to wildtype 
Name Identity Role 
Nuclear 
lamina 
enrichment 
RNAi 
phenotype 
daf-12 
(rh61rh411) 
nrde-3 
(gg066) 
pal-1 Homeodomain protein 
Specification of posterior 
blastomeres Low 
Emb. 
lethality NSD NSD 
pos-1 
CCCH-type 
zinc-finger 
protein 
Specification of germ 
cells, intestine, pharynx 
and hypodermis 
Low Emb. lethality NSD NSD** 
glp-1 Notch receptor 
Specification of germline 
and somatic tissues Low 
Emb. 
lethality NSD NT 
elt-2 
GATA-type 
transcription 
factor 
Intestine development Low Emb. lethality NSD NT 
! 75!
 
 
 
 
 
A               B
     
 
Figure 2.19. NRDE-3, a nuclear argonaute, is required for pha-4 RNAi and lin-26 
RNAi.  
Both pha-4 RNAi (A) and lin-26 RNAi (B) cause lethality. Animals were treated with 
pha-4 and lin-26 RNAi and the number of their progeny that grew to adulthood was 
scored. Although NRDE-2 interacts with NRDE-3 and act in the same pathway, its effect 
in RNAi is smaller than that of NRDE-3. The difference in RNAi sensitivity between 
nrde-2 and nrde-3 mutants has been reported in other independent study (ZHUANG et al. 
2013). n=3. Error bars represent standard deviation.  
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Figure 2.20. DAF-12 is required for robust lin-26 RNAi and par-1 RNAi.  
lin-26 RNAi  
(A) and par-1 RNAi (B) lead to lethality. The dotted lines with the slope of one are 
superimposed to the graphs to aid the comparison between the viabilities of wildtype 
(WT) and daf-12(rh61rh411) mutants. Wilcoxon Signed-Rank test indicates p<0.05 for 
both lin-26 RNAi and par-1 RNAi. n=7 for lin-26 RNAi; n=4 for par-1 RNAi. 
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Table 2.2, Fig. 2.21 and Fig. 2.22). The overlap between the lists of genes that required 
DAF-12 or NRDE-3 for silencing raises the possibility that DAF-12 and NRDE-3 act in a 
common pathway. It is also plausible that DAF-12 functions in parallel to the NRDE 
pathway to silence the same cohort of genes. 
DAF-12 acts as a transcription factor and the transcripts of the crucial components 
in the NRDE pathway— nrde-1, nrde-2, nrde-3, and nrde-4—are present in early 
embryos (LEVIN et al. 2012). Therefore, we hypothesized that DAF-12 might activate the 
expression of genes in the NRDE pathway in mothers, leading to a large maternal load 
and strong silencing in progeny. To test this idea, we collected early embryos and 
performed RT-qPCR for NRDE pathway genes. Quantitative PCR analysis using 
F35G12.2 as a reference gene (ZHANG et al. 2012) revealed that the transcript levels of 
nrde-1, nrde-2, nrde-3, and nrde-4 in daf-12 mutants were not significantly different 
from those in wildtype (Fig. 2.23A). We also examined the mRNA level of hrde-1, which 
encodes a germline Argonaute protein involved in the inheritance of RNAi (BUCKLEY et 
al. 2012) and found that DAF-12 did not affect the transcription of hrde-1 (Fig. 2.23A). 
These results suggest that active transcription of the gene targeted by RNAi in daf-12 
mutants is not explained by the low expression of the NRDE factors. 
To address the possibility that DAF-12 modulates some other factors that 
influence the activity of the NRDE pathway, we examined the mRNA levels of genes 
targeted by endogenous small interfering RNA (endo-siRNAs) in early embryos. 
Previous studies have shown that the argonautes in the NRDE pathway—NRDE-3 and 
HRDE-1—are associated with endo-siRNAs and facilitate silencing of genes targeted by 
endo-siRNAs (GUANG et al. 2008; BURKHART et al. 2011; ZHUANG et al. 2013).  
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Figure 2.21. NRDE-3 is not required for pal-1 RNAi and skn-1 RNAi.  
pal-1 RNAi (A) and skn-1 RNAi (B) cause embryonic lethality. Wildtype (WT) and 
nrde-3(gg066) mutants were treated with pal-1 and skn-1 RNAi and the number of their 
progeny that grew to adulthood was scored. The dotted lines with the slope of one were 
drawn to better determine whether the viabilities of wildtype and nrde-3(gg066) mutants 
are similar or different. Wilcoxon Signed-Rank test returned p>0.05 for pal-1 RNAi. The 
p value for skn-1 RNAi was smaller than 0.05, but the fold change was not greater than 
1.5. n=4 for both pal-1 RNAi and skn-1 RNAi. 
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Figure 2.22. DAF-12 is not required for pal-1 RNAi, pos-1 RNAi and skn-1 RNAi. 
pal-1 RNAi (A), pos-1 RNAi (B), and skn-1 RNAi (C) cause embryonic lethality. The 
dotted lines with the slope of one were drawn to better determine whether the viabilities 
of wildtype and daf-12(rh61rh411) mutants are similar or different. Wilcoxon Signed-
Rank test shows p>0.05 for pal-1 RNAi and skn-1 RNAi. The p value for pos-1 RNAi is 
greater than 0.05, but the fold change is smaller than 1.5. n=6 (pal-1 RNAi), 8 (pos-1 
RNAi), and 7 (skn-1 RNAi). 
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Figure 2.22 (continued). DAF-12 is not required for pal-1 RNAi, pos-1 RNAi and 
skn-1 RNAi. 
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Figure 2.23. The activity of the NRDE pathway is not altered in daf-12 mutant 
embryos.  
Total RNAs from wildtype (WT) and daf-12(rh61rh411) mutant embryos were subjected 
to the RT-qPCR analysis. The 2-ΔΔCt method (LIVAK and SCHMITTGEN 2001) was used 
to compare the abundance of specific transcripts in daf-12 mutants to that in wildtype. 
The value of one indicates the same level of the transcript in wildtype and daf-12 mutant 
embryos. n=3. Error bars represent standard deviation. (A) Genes encoding the NRDE 
pathway components. (B) Genes regulated by the NRDE-siRNA pathway. (C) Genes 
regulated by the HRDE-siRNA pathway.  
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E01G4.5, Y46H3C.7, and Y9D1A.1 are among the genes targeted by NRDE-3-
interacting endo-siRNAs (GUANG et al. 2008; BURKHART et al. 2011). Lack of NRDE-3 
increases the mRNA level of E01G4.5 four fold (GUANG et al. 2008). In addition, 
Y46H3C.7, and Y9D1A.1 are highly marked with H3K9me3 in wildtype, but less 
enriched with H3K9me3 in NRDE pathway mutants (BURKHART et al. 2011), indicating 
that transcription of these endo-siRNA target genes are under the control of the NRDE 
pathway. We surveyed these genes to determine the level of activity of the NRDE 
pathway in daf-12 mutants.  Our RT-qPCR analysis revealed that early daf-12 mutant 
embryos showed no difference in the transcript levels of E01G4.5, Y46H3C.7, and 
Y9D1A.1 compared to wildtype (Fig. 2.23B). The HRDE-1 activity seems unchanged in 
daf-12 mutant embryos as well since bath-45, F15D4.5, and B0250.8, which are targeted 
by endo-siRNAs associated with HRDE-1 and up-regulated four fold in hrde-1 mutants 
(BUCKLEY et al. 2012), were transcribed normally in daf-12 mutant embryos (Fig. 
2.23C). In summary, DAF-12 does not significantly change the activity of the NRDE 
pathway and may therefore act in parallel to the NRDE pathway to ensure transcriptional 
repression in response to RNAi.  
 
Discussion 
Here we have identified the C. elegans nuclear hormone receptor DAF-12 as a novel 
RNAi regulator. In C. elegans, RNAi-induced silencing activity persists in the progeny of 
dsRNA-exposed animals (FIRE et al. 1998; GRISHOK et al. 2000; VASTENHOUW et al. 
2006; ALCAZAR et al. 2008). Recent studies have revealed that the inheritance of RNAi is 
associated with the presence of siRNAs and H3K9me3 at the locus targeted by RNAi 
over multiple generations (GUANG et al. 2010; BURTON et al. 2011; BUCKLEY et al. 2012; 
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GU et al. 2012). However, how the silencing response is passed down to and re-
established in progeny is not well understood. In this study, we found that DAF-12 
normally acts in mothers to increase the robustness of RNAi in zygotes. When DAF-12 is 
functional, RNAi-induced silencing is associated with low Pol II occupancy at the pha-4 
target locus, whereas lack of DAF-12 led to an increase in Pol II enrichment, although we 
recognize that post-transcriptional mechanisms may also contribute to the DAF-12 
effects.  
 The role of DAF-12 in RNAi enhancement depends on the availability of DAF-12 
ligands and DAF-12 co-repressors. Based on previous studies, which suggested that 
DAF-12 integrates multiple pathways responding to environmental cues, we tested and 
found that the environmental condition during mother’s development determines the 
effect of DAF-12 on RNAi. 
 
DAF-12 as a novel RNAi regulator 
Almost all factors that are known to alter RNAi efficiency are intrinsic to the RNAi 
process. For instance, a mutation in rde-4, which encodes a dsRNA-binding protein that 
promotes siRNA production (PARRISH and FIRE 2001) confers a strong RNAi-defective 
phenotype (TABARA et al. 1999), whereas worms lacking functional ERGO-1, an 
argonaute involved in endogenous RNAi, show an enhanced RNAi phenotype (YIGIT et 
al. 2006; ZHUANG and HUNTER 2011). Unlike these factors, DAF-12 does not have any 
RNA binding domain (ANTEBI et al. 2000). Then, how could a nuclear hormone receptor 
increase RNAi efficiency? Considering its identity as a transcription factor, it is possible 
that DAF-12 activates expression of some unknown factors in the RNAi mechanism.  
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 In addition to the molecular function, the mode of action of DAF-12 in RNAi is 
unique. pha-4 RNAi treatment decreased Pol II occupancy at the pha-4 locus in wildtype, 
whereas high enrichment of Pol II was detected in the pha-4 gene body in daf-12 mutants 
(Fig. 2.10D and E). This pattern was distinct from that of one of the NRDE pathway 
mutants, where Pol II levels at the targeted locus did not change upon RNAi (GUANG et 
al. 2010). Moreover, RNAi-triggered H3K9me3 modification still appeared in daf-12 
mutants after pha-4 RNAi, whereas a NRDE pathway mutant fails to accumulate 
H3K9me3 at the targeted locus. These results indicate that the mechanism by which 
DAF-12 regulates RNAi is distinct from that of the NRDE pathway.  
 
The contribution of DAF-12 to cross-generational signaling by RNAi 
Two observations suggest that DAF-12 facilitates the inheritance of RNAi, rather than 
promoting the efficiency of RNAi in general. First, daf-12 heterozygous mutants from 
homozygous mothers failed to show the robust RNAi response, indicating that DAF-12 is 
required in mothers to enhance RNAi efficiency in zygotes. Second, daf-12 mutants (P0) 
that were directly exposed to RNAi were as responsive to RNAi as wildtype animals: we 
observed weak pha-4 RNAi phenotypes only in the F1 generation. This characteristic 
distinguishes DAF-12 from other factors—such as RDE-1 and RDE-4—which, when 
mutated, confer defects in the RNAi process in both dsRNA-treated animals and their 
progeny (TABARA et al. 1999; PARRISH and FIRE 2001). 
How could DAF-12 regulate silencing induced in the inheriting zygotes? The 
RNAi process generates two classes of siRNAs —primary and secondary. Primary 
siRNAs are derived from the initial dsRNA by the activity of Dicer (ELBASHIR et al. 
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2001; BERNSTEIN et al. 2001). When primary siRNAs bind to their target transcripts, they 
can act as primers for RNA-dependent RNA polymerase (RdRP) and as a consequence, 
secondary siRNAs are produced (SMARDON et al. 2000; AOKI et al. 2007; GHILDIYAL and 
ZAMORE 2009). A previous study showed that both primary and secondary siRNAs are 
inherited in the progeny (F1) of the animals (P0) directly exposed to dsRNA, although 
the levels of primary and/or secondary siRNAs were much lower in the offspring than in 
the P0 animals (GU et al. 2012). It is possible that DAF-12 increases the number of 
primary or secondary siRNAs deposited into oocytes. daf-12 is expressed in multiple 
tissues including the intestine and gonad (ANTEBI et al. 2000), but its expression has not 
been detected in the germ line or early embryo (BAUGH et al. 2003; REINKE et al. 2003; 
YUZYUK et al. 2009; LEVIN et al. 2012). Intestinal cells need to transport ingested 
dsRNAs or processed siRNAs to the gonad and to the germ line for inheritance (JOSE and 
HUNTER 2007). Therefore, one speculative idea is that DAF-12 facilitates the inter-
cellular transport of silencing signals to the germ line. Another possibility is that maternal 
DAF-12 up-regulates the activity of the RNAi process in zygotes to re-establish the 
silenced state. We found that the expression of the NRDE pathway components and their 
activity were not altered in daf-12 mutants (Fig. 2.23A). Therefore, DAF-12 may regulate 
an unknown factor or process in parallel to the NRDE pathway. If this scenario is the 
case, how daf-12 expressed in somatic cells of mothers can exert an effect in zygotes 
remains to be seen.  
The environmental effect on RNAi 
One of the intriguing findings in our study was that high population density during 
mothers’ larval development restored a strong RNAi phenotype to daf-12 mutants, which 
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had shown a weak RNAi phenotype when cultured in an under-crowded condition (Fig. 
2.15B). In contrast, the strength of the RNAi phenotype was strong in wildtype animals 
regardless of the maternal population density during development (Fig. 2.15B). These 
results suggest that under-crowded conditions can possibly strengthen RNAi response, 
but that DAF-12 mitigates this effect. A previous study proposed that DAF-12 acts as a 
capacitor (or a buffer); environmental fluctuations can be potentially harmful and cause 
phenotypic changes, but DAF-12 minimizes such effect (HOCHBAUM et al. 2011). Our 
work reinforces the role of DAF-12 as a buffer to alleviate any environmental effect on 
physiological changes. 
 Previous studies reported that RNA-defective (Rde) phenotypes in some mutants 
are dependent on temperature (HABIG et al. 2008; HAN et al. 2008). In these studies, 
animals were maintained at a certain temperature for the whole period of RNAi. On the 
contrary, in our experimental setup, crowding versus sparse condition was limited to the 
larval growth of mothers. How could animals “remember” their previous environment 
and alter molecular/physiological phenotypes in embryos? Recently, studies have 
amassed examples where transient experience of certain environmental factors, such as 
pollutants (ANWAY et al. 2005; MANIKKAM et al. 2012; DOYLE et al. 2013) and particular 
diets (CARONE et al. 2010; NG et al. 2010; FULLSTON et al. 2013), in one generation 
could alter the phenotypes of the subsequent generation. For example, when male P0 
mice learned to link a certain odor (acetonphenone) with a noise that provoked a startle 
response, F1 and F2 offspring showed a high sensitivity to the odor, although they were 
never conditioned (DIAS and RESSLER 2013). This work suggests that the memory of the 
exposure could be transmitted across generations. Our study not only provides another 
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example where the memory of an environmental condition long before mating is 
transmitted to zygotes and influences their phenotypes, but also suggests a potential 
interaction between environment and small RNA pathways. 
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CHAPTER III 
 
Summary and Future Directions 
 
Summary 
RNA interference (RNAi) is a cellular process where small non-coding RNAs target and 
silence the expression of the complementary transcripts by transcriptional and post-
transcriptional mechanisms (QUE and JORGENSEN 1998; FIRE et al. 1998; MONTGOMERY 
et al. 1998; GUANG et al. 2008, 2010). In C. elegans, ingested dsRNA can trigger RNAi 
in animals directly exposed to dsRNA and elicit a strong RNAi response in their progeny, 
in which target mRNAs are degraded in response to complementary small RNAs 
(MONTGOMERY et al. 1998; TABARA et al. 1999; TUSCHL et al. 1999; HAMMOND et al. 
2000). Extensive investigations uncovered that a significant level of small RNAs as well 
as the H3K9me3 modification persist in the progeny of dsRNA-exposed animals (GUANG 
et al. 2010; BURTON et al. 2011; GU et al. 2012), indicating that small RNAs and the 
chromatin state may be responsible for the transmission of RNAi across generations or 
are re-established de novo at each generation. A pathway to establish silencing in 
progeny of dsRNA-exposed animals is known, but a maternal contribution to RNAi 
inheritance has not been observed. Here we show that maternal DAF-12 is required for 
robust RNAi in zygotes. Our analyses showed that the DAF-12/nuclear hormone receptor 
is required in mothers to induce strong RNAi phenotypes in zygotes. Pol II ChIP-qPCR 
analysis revealed that DAF-12 enhances RNAi by inhibiting transcription of the targeted 
gene. We also found that the role of DAF-12 in RNAi regulation is independent of other 
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pathways that DAF-12 is involved. These findings implicate that animals exposed to 
dsRNAs are actively engaged in inducing RNAi response in zygotes and that DAF-12 
provides additional layer of regulation in this process. In addition, we discovered that the 
effect of DAF-12 on RNAi was modulated by the environmental conditions during 
mothers’ development, which suggests an intriguing link between the experience of 
environmental cues and RNAi inheritance. Together, the work presented here provides 
insights into cross-generational signaling that modulates RNAi-induced silencing (Fig. 
3.1). Moreover, given the inter-dependent nature of multiple small RNA pathways that 
are involved in various biological mechanisms such as fertility and genome stability, it is 
plausible that the interaction between the environment and the RNAi mechanism may 
affect other biological processes. 
 
Discussion 
Translation of maternal experience into molecular changes in zygotes 
One of the major findings of this study is the requirement of maternal DAF-12 for 
establishment of RNAi-triggered silencing activity in zygotes. Our understanding of 
RNAi inheritance has expended recently, but the identity of molecules that are 
transmitted from dsRNA-exposed mothers to their zygotes is still unknown. The 
identification of DAF-12 acting in mothers as a mediator of RNAi inheritance not only 
highlights a significant role of mother in passing on the silencing response to zygotes, but 
also provides a tool to hunt for the molecules carrying the memory of RNAi-induced 
silencing (see the Future Direction).  
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Figure 3.1 Models for the effects of environment and DAF-12 on RNAi efficiency. 
My work suggests that maternal DAF-12 is required for robust RNAi in zygotes. The 
observations that daf-4/TGF-beta receptor was epistatic to daf-12 and that DAF-12 
became dispensable when worms developed in a crowded condition indicate that DAF-12 
acts either upstream of a neuronal signaling and the TGF-beta pathways (A) or in parallel 
to the TGF-beta pathway responding to environmental cues (B). These two possibilities 
can be differentiated by the further analysis on the genetic interactions between daf-12 
and the components required for the neuronal signaling and the TGF-beta pathways. How 
the effect of DAF-12 on RNAi in zygotes is mediated remains to be seen. ChIP-qPCR 
analysis revealed that DAF-12 promotes a decrease in Pol II occupancy at the pha-4 locus 
upon RNAi, but the RNAi-triggered accumulation of H3K9me3 is not dependent on 
DAF-12. This specific effect makes a contrast to the NRDE pathway, which both inhibits 
the transcription elongation step and increases the level of H3K9me3 at the locus targeted 
by RNAi (GUANG et al. 2010). Thus, we conclude that DAF-12 may regulate RNAi 
independently of the NRDE pathway. It is possible that the DAF-12—DIN-1 repressor 
complex inhibits expression of a gene or genes in the germ line that weaken the RNAi-
induced silencing activity in early embryos. Or DAF-12 may facilitate transport of small 
RNAs derived from the initial dsRNAs into gonad and germ cells to provide a sufficient 
amount of small RNAs to trigger silencing activity in zygotes. Another possibility is that 
an unknown chromatin mark associated with RNAi-induced silencing is inherited to the 
progeny in a DAF-12- dependent manner. 
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A.         B. 
 
Figure 3.1 (continued). Models for the effects of environment and DAF-12 on RNAi 
efficiency. 
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In addition, we found that daf-12 mutants, which normally show a weak RNAi 
response, exhibited robust RNAi when their mothers were reared under the crowded 
environment (Fig. 2.15B). Exposure to crowded environment was limited to during 
mothers’ development, indicating a long-lasting effect of transient maternal experience 
on the phenotype of zygotes. How a memory of experiences could be passed down to the 
future generation remains to be seen, but our finding provides an example, where 
environmental conditions leave a cross-generational impact.  
It is of note that wildtype animals showed no difference in RNAi efficiency upon 
different environmental settings (Fig. 2.15B). How could the environmental conditions 
have an impact only in daf-12 mutants? A plausible explanation is that functional DAF-
12 in wildtype animals acts as a buffer to minimize the effect of environmental changes. 
The role of DAF-12 as a capacitor has been suggested previously, and the similar concept 
could be applied here. Another speculative model is that the requirement of DAF-12 for 
robust RNAi depends on environmental conditions; DAF-12 modulates RNAi efficiency 
only when mothers grow in a less-populated condition. A high population density, on the 
other hand, activates some other components regulating RNAi and DAF-12 is no longer 
needed for robust RNAi. This model explains why we saw the effect of DAF-12 only 
when worms were sparse. 
 
RNAi-induced H3K9me3 enrichment 
One signature of transcriptional repression induced by RNAi is the enrichment of 
H3K9me3 (BURTON et al. 2011; GU et al. 2012), Our H3K9me3 ChIP revealed that both 
wildtype and daf-12 mutants show an increase  in the H3K9me3 level at the region 
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targeted by the initial trigger dsRNA (Fig. 2.11). One caveat of these experiments is the 
mixture of cell types that are monitored. Normally, gut cells express PHA-4 whereas 
other types of cells do not (AZZARIA et al. 1996; KALB et al. 1998). Subjecting whole 
embryos to ChIP might prevent us from recognizing a difference in the foregut-specific 
H3K9me3 enrichment upon pha-4 RNAi. Presumably, the pha-4 locus in non-pharyngeal 
cells, which make up the majority of cells in an embryo, is transcriptionally inactive, and 
likely marked with H3K9me3. Therefore, any slight but significant change in H3K9me3 
at the pha-4 locus in pharyngeal cells may not be detectable when both pharyngeal and 
non-pharyngeal cells were subjected to ChIP. Nevertheless, the increase in H3K9me3 
reveals that changes in response to RNAi were detectable in this experiment.  
 
Transcription inactivation triggered by pha-4 RNAi 
Kennedy and colleagues reported that the elongation step of transcription was inhibited 
by the NRDE pathway during RNAi (GUANG et al. 2010). Comparing the Pol II 
occupancy with or without lin-15b RNAi treatment, the authors observed no change in 
Pol II occupancy near the start of the first exon. However, there was a two-fold increase 
in Pol II enrichment at the region targeted by dsRNA and a dramatic reduction of Pol II 
occupancy downstream of the targeted region. The Pol II level at the 3’ end of the coding 
sequences was half that of samples without RNAi treatment. This Pol II pattern of 
accumulation and decrease was dependent on NRDE-2, an essential nuclear component 
of the NRDE pathway (GUANG et al. 2010). Similarly, Burkhart and colleagues used 
nuclear run-on assays, which capture nascent transcripts (CORE et al. 2008), to show a 
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reduction of transcription downstream of the site targeted by dsRNA (BURKHART et al. 
2011). 
 The change in the Pol II enrichment pattern at the pha-4 locus after pha-4 RNAi 
was very different from what Kennedy and colleagues reported. Upon pha-4 RNAi, Pol II 
occupancy dropped to half of its normal level at the start of coding sequence and 
remained low throughout the gene body (Fig. 2.10D). The discrepancy between the Pol II 
patterns that Guang et al (2010) reported and that we observed could reflect the different 
genes targeted, or differences in silencing between the two studies. For example, pha-4 
likely auto-regulates itself, so a drop in PHA-4 after RNAi may lead to a general drop in 
its own transcription. With either explanation, the observed changes in Pol II occupancy 
suggest that transcription initiation, not elongation, falls after pha-4(RNAi).  
In daf-12 mutants, the Pol II enrichment at the pha-4 gene body increased two 
fold after RNAi (Fig. 2.10D and E). The difference in Pol II occupancy near the promoter 
region was insignificant, but the regions before and after the site targeted by the initial 
trigger dsRNA showed high Pol II enrichment (Fig. 2.10D and E). This trend seems 
different from that of stalled Pol II during the elongation step, which is characterized by a 
greater than four-fold decrease in the level of Pol II bound to DNA downstream of the 
region targeted by dsRNA (GUANG et al. 2010). Whether a two-fold increase in the Pol II 
enrichment at the gene body reflects more transcription needs to be determined, but the 
opposite directions of the Pol II accumulation in wildtype embryos versus daf-12 mutants 
(a decrease in wildtype and an increase in daf-12 mutants) raises the possibility that 
DAF-12 mediates responses to RNAi at the transcription level, either directly or 
indirectly.  
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What could explain RNAi-triggered accumulation of Pol II in daf-12 mutants? A 
speculative model is that there is a mechanism that promotes transcription in response to 
RNAi, but this mechanism is inhibited by DAF-12 in embryos. The notion that dsRNA 
treatment can elicit transcriptional activation seems counter-intuitive, as exposure to 
dsRNA is known to reduce the expression level of the targeted gene. However, recent 
studies have identified an “anti-silencing” mechanism that involves the same type of 22G 
siRNAs that can also trigger silencing, depending on the proteins bound to the siRNA 
(Fig. 1.2) (CONINE et al. 2013; SETH et al. 2013; WEDELES et al. 2013). The dual role of 
siRNAs in germline gene expression/silencing implies that there may be a similar 
interaction between small RNA pathways for exogenous RNAi. Such “anti-silencing” 
pathway for exogenous RNAi and its interaction with DAF-12 remain enigmatic at this 
moment, but it would be an interesting future direction.  
 
Distinct roles of DAF-12 in RNAi enhancement and developmental timing pathways 
Our mutant analysis indicates that DAF-12 regulates RNAi via a novel pathway that is 
distinct from dauer formation and heterochronic pathways. We examined pha-4 RNAi 
efficiency of multiple daf-12 mutants that exhibit different dauer phenotypes and varying 
degrees of severity in heterochronic phenotypes. A wide range of phenotypes among daf-
12 mutants is attributed to the positions and the natures of mutations in daf-12, which are 
likely to alter its affinity to the ligand or the co-repressor DIN-1. The resulting changes in 
the ratio of unliganded DAF-12 and liganded DAF-12 may confer varying degrees of 
mutant phenotypes. However, the weak pha-4 RNAi phenotype was universal among 
daf-12 mutants tested in the study. This result raises the possibility that even a subtle 
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deviation from the normal ratio of unliganded DAF-12 to liganded DAF-12 may alter the 
efficiency of pha-4 RNAi. Our analysis with nhr-8 and din-1 mutants further suggests 
that an increase in the DAF-12—DIN-1 repressor complex and a (reciprocal) reduction of 
liganded DAF-12 enhance silencing induced by RNAi. These findings suggest that, like 
other pathways in which DAF-12 is involved, the role of DAF-12 in RNAi also relies on 
the availability of its ligands, Dafachronic acids. How could one input—biosynthesis of 
DA and its binding to DAF-12—elicit three different responses? One possibility is that 
different thresholds of the ratio of unliganded DAF-12 to liganded DAF-12 are required 
for a certain phenotype to appear. For instance, the enhanced RNAi phenotype might 
require a slight increase in the level of DAF-12—DIN-1 complex, whereas the dauer 
phenotype might depend on a high concentration of DAF-12—DIN-1 complex. 
Alternatively, our analysis with multiple daf-12 mutants demonstrates the importance of 
the fine-tuning process of the DAF-12 function in physiological changes. 
 
The effect of dsRNA dosage on the role of DAF-12 in RNAi 
Through serial dilution of RNAi food with neutral RNAi bacteria, we noticed that the 
effect of DAF-12 on RNAi enhancement was greatest when enough dsRNA was supplied 
for killing >50%. As dsRNA was diluted, daf-12 mutants no longer showed a significant 
decrease in RNAi-induced lethality. This observation suggests that the amount of dsRNA 
should be above a certain level to trigger DAF-12-mediated RNAi inheritance. Further 
investigation in the mechanism by which DAF-12 enhances RNAi inheritance may 
explain the existence of threshold for DAF-12 to function. 
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Future Directions 
Mechanisms by which maternal DAF-12 promotes RNAi in zygotes 
The requirement of DAF-12 in mothers for robust RNAi in zygotes leaves a question of 
how this non-conventional maternal effect occurs. To answer this question, it would be 
informative to know when and where daf-12 needs to be expressed in mothers to enhance 
RNAi in zygotes. daf-12 is expressed in multiple tissues, including some neurons, 
pharynx, and intestine (ANTEBI et al. 2000). Tissue-specific expression of daf-12 would 
be a good method, except that one should be cautious about using transgenes. We have 
encountered the issues where transgenic worms carrying transgenes are insensitive to 
pha-4 RNAi (see Appendix). Use of single copy transgenes could solve this problem and 
aid the identification of the critical tissue(s) for DAF-12 function. Narrowing down the 
developmental time window, when DAF-12 is required, could be challenging. However, 
a tool recently developed by Judkins and his colleagues may help researchers have a tight 
temporal control of DA availability (JUDKINS et al. 2014). An experimental scheme 
would include 1) feeding daf-9 mutant worms, which cannot synthesize DA, with 
photocleavable amides of 5-methoxy-N-methyl-2-nitroaniline (MMNA)-protected DA; 2) 
exposing worms to UV irradiation at various time points during larval development; 3) 
performing pha-4 RNAi and examining RNAi phenotypes in offspring. Using this 
technique, one could pinpoint a specific developmental period when DAF-12 influences 
RNAi inheritance. Identification of the spatial and temporal requirements of DAF-12 for 
RNAi enhancement would help us to better understand how parents exposed to dsRNA 
can ensure the robust RNAi in zygotes.  
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 In the current study, we examined the effect of DAF-12 on RNAi targeting genes 
functioning during embryogenesis. An interesting future question is whether DAF-12 can 
enhance RNAi targeting genes that are expressed later in development. For instance, it 
was proposed that NRDE-3 is required for silencing genes that function during larval 
development (BURTON et al. 2011). Given our experiments, which showed that NRDE-3 
is required for robust pha-4 RNAi and lin-26 RNAi, both of which cause embryonic 
lethality, the NRDE pathway is required for heritable silencing of genes expressed during 
embryogenesis. Experiments, where wildtype and daf-12 mutants are fed with dsRNA 
targeting genes required later in development, would answer the question of whether the 
DAF-12 effect on RNAi is limited to embryonic genes or not. In our preliminary 
experiments, daf-12 mutants exhibited strong dpy-11 RNAi phenotype, whereas previous 
studies reported that NRDE-3 is required for robust dpy-11 RNAi (GUANG et al. 2008; 
ZHUANG et al. 2013). More experiments with multiple RNAi would be required to obtain 
a solid conclusion. Of note, silencing genes that are expressed during larval stages might 
cause a range of phenotypes, not the binary, life or death, choices that we saw for pha-4 
and lin-26. For instance, a small change in Unc (uncoordinated) or Dpy (dumpy) 
phenotypes could be hard to discern. Therefore, meticulous observation and quantitation 
would be required to spot any significant effect on the efficiency of RNAi. 
 
How could daf-12 mediate RNAi inheritance? 
The current work presents an interesting cross-generational effect of DAF-12 on the 
RNAi efficiency. However, we do not know what mediates this effect. Any molecular 
signatures of RNAi—primary siRNA, secondary siRNA, and/or H3K9me3—could be the 
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critical effector of DAF-12. For instance, DAF-12 may change the amount of primary 
and/or secondary siRNAs deposited into oocytes. It is also possible that a zygotic factor 
that is regulated by DAF-12 in mothers plays a role in consolidating the silenced state of 
the gene targeted by RNAi. Analysis of the expression profiles of genes expressed in 
wildtype and daf-12 germ lines and ChIP of DAF-12 protein (HOCHBAUM et al. 2011) 
may provide a clue of what factors mediate the DAF-12 effect. Most studies about DAF-
12 have focused on its role in the processes occurring in one generation, such as larval 
development or longevity. Significant differences in the composition of maternally 
deposited factors between wildtype and daf-12 have not been described but might reveal 
other candidates that are determine the potency of cross-generational signaling. 
 
The contribution of the environment to RNAi 
The environmental contribution to the DAF-12 effect on RNAi seems rather specific; 
cholesterol starvation decreased RNAi sensitivity in wildtype animals (See Appendix), 
whereas under-crowding versus over-crowding did not alter the RNAi phenotypes. 
Instead, the population density determined the influence of DAF-12 on RNAi 
enhancement. These results indicate that different environmental cues activate separate 
pathways to regulate RNAi efficiency. What pathways would be strong candidates to 
modulate RNAi in response to external conditions? Transduction signaling pathways that 
link certain environmental factors (i.e. chemicals or temperature) to physiological 
changes are well studied in C. elegans, compared to other model systems. We decided to 
look into TGF-beta dauer pathway due to its link with environmental inputs and DAF-12; 
it was known that a high concentration of a pheromone, which implies high population 
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density, inactivates the expression of TGF-beta ligand (REN et al. 1996; SCHACKWITZ et 
al. 1996), thus turning off the downstream pathway . Moreover, expression of the 
enzymes required for DA biosynthesis is determined by TGF-beta dauer pathway (JIA et 
al. 2002; GERISCH and ANTEBI 2004), indicating that this signaling pathway modulates 
the activity of DAF-12. In an attempt to test whether TGF-beta is involved in RNAi 
regulation, we tested TGF-beta pathway mutants with pha-4 RNAi and discovered some 
candidate genes that may be involved in the pha-4 RNAi regulation (Fig. 2.17B). We 
have not tested yet whether TGF-beta pathway mutants show weak RNAi in general or 
not. Therefore, it is not clear whether TGF-beta pathway influences RNAi efficiency or 
PHA-4 activity. 
Among TGF-beta mutants, we chose worms carrying a deletion mutation in daf-4, 
which encodes TGF-beta receptor type II (ESTEVEZ et al. 1993), and looked at the genetic 
relationship between daf-4 and daf-12. The epistasis analysis revealed that lack of DAF-
12 did not alter RNAi efficiency in daf-4 mutant background, just like crowded 
environmental condition (Fig. 2.18). The observation that both highly populated 
condition and a daf-4 mutation, which confers constitutive dauer formation as if worms 
experience unfavorable environment, nullified the effect of DAF-12 on RNAi suggests 
the environmental effect on the robustness of RNAi.  
An interesting future question to address is how environmental cues perceived by 
neurons could regulate the robustness of RNAi in the zygotes. Sensory neurons are 
located in the head of a worm, therefore they need a means to reach other tissues and 
ultimately germ line to modulate RNAi inheritance. Hormonal signals may facilitate such 
a long-distance communication between neurons and germ line. It has been shown that 
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ASI neurons in the head of an animal can communicate with the distal tip cells located in 
the gonad to regulate germ line development (DALFÓ et al. 2012). Together, 
identification of the sensory input, neurons, signaling transduction pathways connecting 
the neuronal activity and changes in germ line would help us put a complete picture of 
how environmental information in the parental generation could modulate the strength of 
RNAi in zygotes.  
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APPENDIX I 
 
Non-genetic Factors That Regulate RNAi Efficiency 
 
Introduction 
Previous studies have identified numerous genes that can modulate exogenous RNAi 
activity. For instance, a mutation in rde-4, which encodes a dsRNA-binding protein 
(TABARA et al. 1999), confers a strong RNAi-defective phenotype, whereas worms 
lacking functional ERGO-1, an argonaute involved in endogenous RNAi, exhibit an 
enhanced RNAi phenotype (YIGIT et al. 2006; ZHUANG and HUNTER 2011). Although we 
have gained a comprehensive view of the RNAi process from these studies, we have little 
understanding of whether and what non-genetic, environmental factors alter the 
efficiency of RNAi. While studying the role of DAF-12 in RNAi inheritance, we 
identified some internal and external factors that change the efficiency of exogenous 
RNAi in zygotes. Brief descriptions of the methods and discussion are presented here. 
The underlying mechanisms remain to be determined. 
 
Materials and Methods 
Worm maintenance and pha-4 RNAi 
Worms were maintained and pha-4 RNAi was done as described in Chapter 2 
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Ablation of ASI and ASK neurons 
Animals were hatched and grown at 25°C. Worms at the L3 stage were washed off plates 
and incubated in 1ml of M9 containing 10mM of DiD (Invitrogen #904534) at 25°C for 
two hours with rocking. After incubation, worms were washed three times with M9 and 
transferred on a plate with OP50 food for 30 min. Three to five dye-filled L3 stage 
worms were immobilized on a 10% agar pad containing 20mM of sodium azide and 
covered with a coverslip. A pair of ASI, ASK, or ADL neurons was subjected to laser 
ablation. Once the fluorescent dye was no longer present in the cell body of the neurons, 
worms were washed off from the agar pad and recovered on an OP50-seeded plate at 
25°C. Mock-ablated worms were treated the same way except laser firing was omitted. 
When worms reached the L4 stage, they were subjected to pha-4 RNAi or elt-2 RNAi as 
described above with one modification; instead of 15 worms, two or three L4 worms 
were placed per RNAi plate. 
 
Results and Discussion 
Cholesterol starvation in parents causes resistance to pha-4 RNAi in zygotes 
C. elegans cannot synthesize cholesterol de novo (ROTHSTEIN 1968), thus dietary 
cholesterol is absolutely required for their development. Deprivation of cholesterol leads 
to defects in molting (YOCHEM et al. 1999) and facilitates the entry into the dauer stage 
(GERISCH et al. 2001). To determine whether cholesterol deprivation alters pha-4 RNAi 
efficiency, we reared worms on cholesterol-deficient (vehicle only) plates from birth to 
the fourth larval stage and treated them with pha-4 RNAi (Fig. 4.1). Of note, the worms 
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that grew without cholesterol underwent normal larval growth due to maternally 
deposited cholesterol and perhaps low levels of cholesterol in the media.  
We found that the progeny of animals that were deprived of cholesterol during 
larval growth were four times more viable than those from animals that were 
supplemented with cholesterol (Fig. 4.2). This result indicates that pha-4 RNAi was less 
effective when worms were grown without dietary cholesterol. This observation implies 
that a subtle change in cholesterol metabolism affects RNAi activity. 
Dietary cholesterol is processed to become Dafachronic acids, which are the 
ligands of DAF-12 (MOTOLA et al. 2006; MAHANTI et al. 2014). Therefore, we 
hypothesized that dietary cholesterol would enhance RNAi via DAF-12 by promoting the 
unliganded version of DAF-12. However, like wildtype animals, daf-12(rh61rh411) null 
mutant embryos also showed less pha-4(RNAi)-associated lethality when their parents 
were grown without cholesterol (Fig. 4.2). This result suggests that the effect of dietary 
cholesterol on RNAi enhancement is independent of DAF-12.  
There are two issues that should be resolved in future studies. First, it is possible 
that pha-4 RNAi bacteria express less pha-4 dsRNA when seeded on cholesterol-
deficient plates and therefore worms show less severe RNAi phenotypes. To circumvent 
this issue, an alternative method of RNAi, such as soaking worms in a dsRNA solution or 
injecting dsRNAs into worms, could be used. Second, one needs to test RNAi against 
multiple genes to determine whether the effect of cholesterol on RNAi is general or 
specific to pha-4. 
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Figure 4.1. A schematic diagram of the experiment to test the role of dietary 
cholesterol in RNAi.  
Worms (P0) were hatched and grew either without cholesterol (pink; ethanol—the 
solvent of cholesterol—was added to the plate) or with 5mg/ml of cholesterol (blue). Due 
to the maternally deposited cholesterol, the worms reared on the plate devoid of 
cholesterol (left; pink) underwent normal larval growth. When animals reached the fourth 
larval stage (L4), 15 worms from each treatment were transferred to the plates that were 
seeded with pha-4 dsRNA-expressing bacteria. Later, the viability of the progeny (F1) 
was scored. 
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Figure 4.2. Cholesterol deprivation decreased the pha-4 RNAi efficiency.  
Animals were incubated with or without cholesterol throughout their larval development 
and exposed to pha-4 RNAi when they were at the fourth (last) larval stage. The animals 
produced progeny that exhibited different levels of pha-4 (RNAi)-associated lethality. 
n=3. * p<0.05 (Student t-test). 
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Extra-chromosomal arrays prevent strong response to pha-4 RNAi. 
When injected with mixtures of DNA molecules, C. elegans has the ability to form an 
array that can propagate through mitosis and meiosis (MELLO et al. 1991). This extra-
chromosomal array is typically composed of repetitive sequences (thus high-copy 
number) of the injected DNA molecules and sometimes subjected to transcriptional 
repression (MARTIN and WHITELAW 1996; HSIEH and FIRE 2000). High-copy extra-
chromosomal arrays exhibit the characteristics of heterochromatin; they are enriched with 
H3K27me3 and H3K9me3 (YUZYUK et al. 2009; BESSLER et al. 2010; MEISTER et al. 
2011), which are associated with inactive transcription. Moreover, the extra-
chromosomal arrays are usually found at the periphery of a nucleus (TOWBIN et al. 2011). 
 Anecdotally, we noticed that animals carrying high-copy number transgenes 
inhibited pha-4(RNAi)-associated lethality. Therefore, we designed an experiment to test 
the effect of extra-chromosomal arrays on RNAi. The pRF4 plasmid, which encodes a 
dominant mutant collagen, is commonly used as a co-injection marker due to its distinct 
“Roller” phenotype (KRAMER et al. 1990; MELLO et al. 1991; EVANS 2006). We injected 
pRF4 plasmids mixed with sperm testis DNA into wildtype worms and crossed the 
resulting lines (“roller” lines) with daf-12(rh61rh411) to generate a daf-12 mutant strain 
stably carrying the extra-chromosomal array composed of multi-copy pRF4 plasmids. 
Wildtype and daf-12 mutant Rollers produced Roller progeny at a rate of 70% and 66%, 
respectively, due to the partial transmission of the array. We exposed Rollers and non 
Rollers (F1) from Roller parents (P0) to pha-4 dsRNA and found that the viability of 
progeny (F2) from Rollers was 15 times higher than that of progeny from non Rollers 
(Fig. 4.3). Offspring of the daf-12 mutants carrying pRF4 also showed two fold higher  
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Figure 4.3. The presence of extra-chromosomal arrays repressed pha-4 RNAi. 
Animals (Rol) carrying extra-chromosomal arrays that consisted of multiple copies of a 
pRF4 plasmid, which encodes a dominant mutant allele of rol-6 (KRAMER et al. 1990; 
MELLO et al. 1991), were treated with pha-4 RNAi. For comparison, animals that did not 
carry extra-chromosomal arrays (nonRol) were also treated with pha-4 RNAi. The 
viabilities of their progeny were scored. n=3. *p<0.05 (Student t-test). 
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viability than progeny of non Rollers and daf-12 mutants (Fig. 4.3), suggesting that the 
role of extra-chromosomal arrays in RNAi is in parallel with the role of DAF-12. 
 How can a multi-copy extra-chromosomal array inhibit pha-4 RNAi? The 
observations that heterochromatin formation is implicated in transcriptional repression of 
the array (YUZYUK et al. 2009; BESSLER et al. 2010; MEISTER et al. 2011) and of a gene 
targeted by RNAi (GUANG et al. 2010; GU et al. 2012) may give us a clue. It is possible 
that the extra-chromosomal array titrates factors that are required for transcriptional 
inactivation away from the gene targeted by dsRNA, and as a consequence, the efficiency 
of RNAi is reduced. This argument would predict that the effect of a transgene on RNAi 
could be generalized to other genes targeted by the transcriptional RNAi pathway, not 
specifically to pha-4. Moreover, given that integrated arrays with a low-copy number are 
less likely to be silenced (PRAITIS et al. 2001; FRØKJÆR-JENSEN et al. 2008), transgenes 
may have an effect on RNAi in a copy-number dependent manner.  
Transgenes encoding the wildtype version of an endogenous gene is commonly 
used to rescue mutant phenotypes. The effect of transgenes on RNAi described above 
indicates that one may need to be careful in drawing a conclusion from the experiments 
testing transgenic worms on RNAi, because the effect, if any, could come from the 
presence of transgene itself, independent of its sequence. 
 
Older animals are more susceptible to RNAi than younger worms 
As organisms age, their physiological functions deteriorate. Like vertebrates, C. elegans 
exhibits the characteristics of aging, such as reduction in muscle mass (HERNDON et al. 
2002; EVASON et al. 2005), the decline in axon regeneration (BYRNE et al. 2014), and 
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altered sensitivity to sensory inputs (TSUI and VAN DER KOOY 2008). Young, wildtype C. 
elegans hermaphrodites produce viable embryos for 3-4 days (LUO et al. 2009), and even 
after reproduction ceases, they live for weeks (SHI and MURPHY 2013). To determine 
whether aging has an effect on RNAi sensitivity, we exposed worms of different ages 
(12hr, 24hr, 36hr, and 48hr-post-L4 stage) to pha-4 RNAi for 12 hours at 25°C and 
examined the viability of the progeny (Fig. 4.4A). Interestingly, the viability of the 
progeny of older worms (36hr and 48hr-post-L4) produced was only about 1/4 of that of 
younger worms (Fig. 4.4B), indicating that RNAi was enhanced in the offspring from 
older worms. Like wildtype animals, progeny of older daf-12 mutants exhibited higher 
pha-4 RNAi-induced lethality than that of younger daf-12 mutants, suggesting that DAF-
12 is not engaged in the effect of aging in RNAi (Fig. 4.4C). lin-26 RNAi produced a 
similar pattern, where RNAi was more effective in older animals than younger worms 
(Fig. 4.4D). These results suggest that the aging process may generally enhance RNAi. 
Currently, it is not clear whether old adults or their progeny are responsible for 
enhanced RNAi phenotypes; it is possible that any physiological or molecular changes in 
aged worms increases the amount of silencing signals inherited in zygotes, thereby 
aggravating RNAi phenotypes in zygotes. Alternatively, zygotes of older worms may be 
highly sensitive to RNAi for unknown reasons. Further investigation would be required 
to identify the aging-related processes that increase the RNAi efficiency.  
 
Disruption of neuronal network enhances RNAi sensitivity in embryos 
C. elegans have twelve amphid neuron pairs whose ciliated endings are exposed to the 
environment (BARGMANN 2006). Among these chemosensory neurons, ASI neurons not  
! 111!
 
 
 
 
 
 
Figure 4.4. Aged animals increased the efficiency of feeding RNAi.  
(A) A timeline of the experiment to test the effect of aging on the RNAi efficacy. Worms 
(P0) with different ages (12, 24, 36, and 48hr-post-L4) were treated with RNAi for 10hrs 
to purge any germ cells produced before the uptake of dsRNA and initiate RNAi. Then, 
the worms (P0) were transferred to new RNAi plates and their embryos (F1) were 
collected in two hours. Two days later, viabilities of F1 were scored. (B and C) Wildtype 
(B) and daf-12(rh61rh411) (C) were treated with pha-4 RNAi and viabilities of their 
progeny were recorded. n=3. Error bars represent standard deviation. (D) Like pha-4 
RNAi, lin-26 RNAi causes lethality. Wildtype worms with different ages were treated 
with lin-26 RNAi and the numbers of their viable progeny were counted. n=3. Error bars 
represent standard deviation. 
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Figure 4.4 (continued). Aged animals increased the efficiency of feeding RNAi.  
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only sense temperature and certain chemicals (BARGMANN and HORVITZ 1991; BEVERLY 
et al. 2011), but also promote reproductive growth and dietary restriction-induced 
longevity, indicating that signals from ASI neurons can result in systemic changes 
throughout the organism (HUKEMA et al. 2006; BISHOP and GUARENTE 2007). To 
determine the role of environmental cues in RNAi, we decided to ablate the ASI neurons 
and test whether their absence altered RNAi efficiency. Many laser ablation studies have 
used transgenic worms that mark specific neurons to aid ablation. However, considering 
the aforementioned observation that the presence of a transgene itself changes RNAi 
sensitivity, we decided to avoid using any transgenic strains. Instead, we treated third 
stage larvae with DiD to label the amphid neurons (Fig. 4.5A and B) and ablated ASI 
neurons using laser (FANG-YEN et al. 2012). ASI neurons were identified by their 
position and morphology. After recovery and growth to the fourth larval stage, mock-
ablated and ASI-ablated worms were treated with pha-4 or elt-2 dsRNA, which also 
causes lethality. We found that the progeny of ASI-ablated worms showed more severe 
RNAi phenotypes than control (mock-ablated) worms that were treated identically except 
for laser firing (Fig. 4.5C). The enhanced RNAi phenotype was not specific to ASI 
ablation because ablation of ASK chemosensory neurons positioned close to ASI neurons 
(Fig. 4.5B) also increased pha-4 (RNAi) lethality (Fig. 4.5C). It is not yet clear whether 
the high sensitivity to RNAi is a phenotype produced by disrupted neuronal network or a 
specific feature of ASI and ASK ablation. However, preliminary data with ADL neuron 
ablation suggest that not all ablated neurons lead to enhanced RNAi (Fig. 4.5C). Of note, 
we cannot rule out the possibility that laser exposure itself during larval growth produces 
such effects.  
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Figure 4.5. ASI and ASK neuron ablation increased RNAi sensitivity in wildtype 
embryos.  
(A) Positions of amphid neurons (lateral view; from neuronbank.org)  (B) Amphid 
neurons were labeled with a fluorescent lipophilic dye DiI prior to ablation to identify 
ASI and ASK neurons. (C) The third larval stage worms were dye-filled, mounted on an 
agar pad and subjected to laser ablation. Control worms (mock-ablated worms) were 
treated the same way except for laser firing. When ablated worms and mock-ablated 
worms were recovered and grew to the fourth larval stage, they were treated with pha-4 
or elt-2 RNAi and viability of their progeny was scored. Normalized viabilities of 
progeny from ASI-ablated worms (grey squares) and ASK-ablated worms (grey circles) 
after pha-4 RNAi was significantly lower than 1 (dotted red line), suggesting that 
neuronal ablation or laser exposure caused enhanced pha-4 RNAi phenotype. Moreover, 
progeny of ASI-ablated worms showed lower viability after elt-2 RNAi treatment (white 
squares) than that of mock-ablated worms. ADL ablation (grey diamond) was performed 
as well, but due to a small sample size and a high variance, it was hard to draw any 
conclusion yet. n>3. 
!  
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Figure 4.5 (continued). ASI and ASK neuron ablation increased RNAi sensitivity in 
wildtype embryos.  !  
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APPENDIX II 
 
Additional Genes That Alter pha-4(RNAi) Lethality 
 
In addition to TGF-beta pathway mutants, I tested worms carrying mutations in the BMP-
like signaling pathway (also called DLB-1 pathway or SMA pathway) and let-7 
microRNA. BMP-like pathway is triggered by DBL-1, a C. elegans homologue of 
Drosophila decapentaplegic and the vertebrate bone morphogenetic proteins (SUZUKI et 
al. 1999). Active BMP-like pathway (Fig. 4.6A) regulates biological processes such as 
body size (SUZUKI et al. 1999; MORITA et al. 2002), innate immunity (MALLO et al. 
2002; ZUGASTI and EWBANK 2009; ROBERTS et al. 2010), and metabolism (ROBERTS et 
al. 2010). Among five BMP-like pathway mutants I tested, daf-4 and sma-9 mutants 
showed strong pha-4 RNAi response (Fig. 4.6B). As mentioned above, DAF-4 is a TGF-
beta type II receptor acting in both TGF-beta dauer pathway and BMP-like pathway 
(ESTEVEZ et al. 1993; SAVAGE et al. 1996; MORITA et al. 1999; GUNTHER et al. 2000). 
Therefore, it would be interesting to know whether DAF-4 regulates pha-4 RNAi via the 
TGF-beta dauer pathway, the BMP-like pathway, or both. SMA-9 is one of the 
transcription factors acting downstream of the BMP-like pathway (Fig. 4.6A) (LIANG et 
al. 2003; SAVAGE-DUNN et al. 2003). Interestingly, a microarray study revealed that 
some genes expressed in germ line are up-regulated in sma-9(wk55) mutants (LIANG et 
al. 2007). Feeding sma-9 mutants with various RNAi food would help us determine 
whether SMA-9 is involved in RNAi in general or specifically interacts with pha-4.  
 Another mutant strain that showed strong pha-4(RNAi)-associated lethality was  
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Figure 4.6. The BMP-like signaling pathway may regulate pha-4 RNAi. 
(A) The BMP-like pathway in C. elegans (modified from SAVAGE-DUNN 2005). (B) The 
BMP-like pathway mutants were treated with pha-4 RNAi and the viabilities of their 
progeny were scored. n=3. Error bars represent standard deviation. 
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let-7(n2853) (Fig. 4.7). let-7 is a well-conserved microRNA (PASQUINELLI et al. 2000) 
and plays a crucial role in developmental timing in C. elegans (REINHART et al. 2000). 
We were interested in let-7 microRNA because it is a downstream target gene of DAF-12 
(HAMMELL et al. 2009). Moreover, daf-12 itself is a target of let-7, forming a negative 
feedback loop (GROßHANS et al. 2005; ZHANG et al. 2007; HAMMELL et al. 2009). Of 
note, it has been suggested that let-7 targets pha-4 and down-regulates pha-4 expression 
in the intestine (GROßHANS et al. 2005). However, changes in the translation rate and 
degradation of pha-4 transcripts were not observed in let-7 mutants (DING and GROßHANS 
2009). Therefore, down-regulation of pha-4 expression by let-7 is rather controversial.  
To test whether let-7 regulates pha-4 RNAi, we grew let-7(n2853) temperature 
sensitive strains at the permissive temperature and treated them with pha-4 RNAi at the 
restrictive temperature. Compared with N2 wildtype animals, let-7 mutants exhibited 
stronger pha-4 RNAi response (Fig. 4.7), which is the opposite behavior of daf-12 null 
mutants. These opposing pha-4 RNAi phenotypes of let-7 and daf-12 mutants would 
allow us to run epistasis analysis in the future to determine whether the relationship 
between DAF-12 and let-7 described above is important in RNAi regulation. 
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Figure 4.7. let-7 mutants show robust pha-4 RNAi 
N2 (wildtype) and let-7(n2853; temperature sensitive) mutants were maintained at the 
permissive temperature and then treated with pha-4 RNAi at the restrictive temperature. 
The grey dotted line was drawn on the graph to help compare the viability of let-7 
mutants to that of N2. n=2. 
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APPENDIX III 
 
C. elegans strains used in this study 
 
Table 4.1. Strain names and genotypes of C. elegans strains used in this study. 
Strain Name  Genotype 
AA1  daf-12(rh257) X 
AA411  din-1(dh149) II 
AA82  daf-12(rh284) X 
AA83  daf-12(rh62rh157) X 
AA88  daf-12(rh193) X 
AA89  daf-12(rh274) X 
CS1  sma-9(wk55) X 
DR1369  sma-4(e729)III 
DR1605  daf-5(m512) II 
LT153  sma-3(wk28) III 
LT186  sma-6(wk7) II 
LT85  sma-3(wk20) III 
MT7626  let-7(n2853) X 
RB2589  daf-3(ok3610) X 
SM2020  daf-12(rh61rh411) X 
SM2021  Wildtype sibling of SM2020 
SM2067  smg-1(cc546 ts)I ; pha-4 (q500) rol-9 (sc148)V; daf-12 (rh61rh411)X 
SM2068  smg-1(cc546 ts)I ; pha-4 (q500) rol-9 (sc148)V.  WT sibling of SM2067 
SM2076  pha-4(q500) rol-9(sc148)/ fog-2(q71) V; daf-12(rh61rh411) X 
SM2077  pha-4(q500) rol-9(sc148)/ fog-2(q71) V. WT sibling of SM2076 
SM2134  wildtype sibling of SM2135, SM2136m and SM2142 
SM2135  daf-12(rh61rh411) X 
SM2136  daf-4(e1364) III; daf-12(rh61rh411) X 
SM2142  daf-4(e1364) III 
SM2172  smg-1(cc546ts) I; ergo-1(tm1860) pha-4(zu225) V 
SM2234  smg-1(cc546ts) I;  pha-4(zu225) V. Wildtype sibling of SM2235. 
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Table 4.1 (continued). Strain names and genotypes of C. elegans strains used in this 
study. 
Strain"Name" " Genotype"
SM2235  smg-1(cc546ts) I;  pha-4(zu225) V; daf-12(rh61rh411) X 
SM2255  Wildtype sibling of SM2256, SM2257, SM2258 
SM2256  nhr-8(ok186) IV 
SM2257  daf-12(rh61rh411) X 
SM2258  nhr-8(ok186) IV; daf-12(rh61rh411) X 
SM2280   ltIs37 [pie-1p::mCherry::his-58 (pAA64) + unc-119(+)].  Wildtype sibling of SM2281. Hermaphrodites and males 
SM2281   daf-12(rh61rh411) X; ltIs37 [pie-1p::mCherry::his-58 (pAA64) + unc-119(+)]. Hermaphrodites and males 
SM2284  pxEx559 [rol-6 (su1006) from PRF4] 
SM2340  daf-12(rh61rh411) X; pxEx559 [rol-6 (su1006) from PRF4] 
YY158  nrde-3(gg66) X 
YY186  nrde-2(gg91) II 
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APPENDIX IV 
 
Primer sequences used in this study 
Table 4.2. Primer sequences. 
Target 
gene Target region Sequence Role 
hrde-1 
exon 1/2 CGA CGT CAA AGA GAA GTG CAC C 
NRDE pathway 
genes 
(RT-qPCR) 
exon 2 GGG CAT ATC CTT GAT GTC CAC TGG 
nrde-1 
N/A ACG CTA GAA GAG CTA ATC GAA GTG 
N/A GGG CTT TCT ACA GCC TCT CTG TC 
nrde-2 N/A GTG GTA CTG GCA AAC ATA CAG GCC 
N/A CGA TTC GCG GAA GAC CAG ATT C 
nrde-3 
exon 3/4 AAT CCA CCA ATC TAC ACG CGT GG 
exon 4 GGA AAG TTC CCG ACG AAT AGA GC 
nrde-4 exon 11 GCG GAT GTA TCT CGA TCA GGC 
exon 12 ACG CTT CAT TAA CAG CTG TAG ACC 
Y46H3C.7 N/A CAG TTC TTA CGG TGT AGA GCA TCA C 
NRDE pathway 
targets  
(RT-qPCR) 
N/A CGT TCC TTC TTC TTC TGT TGT TCT C 
Y9D1A.1 N/A TAA AGA CGA CGA AGA AGG ATC GG 
N/A CGT CGT CTT TAT TGT AGA TGT TTC CG 
C01A2.1 
exon 1 TGA AGA AGA CGA GCT TCT GAA AG 
exon 2 GAG CTT TAC TGT TTC TTG TGA CCA TTG 
bath-45 
exon 5/6 TCT ATG TCT TAA AGC AGA TCC TCG C 
HRDE-1 target 
genes  
(RT-qPCR) 
exon 6 CCA TAC ATG ACC TCC ACA AGA TTC TG 
F15D4.5 
exon 3/4 AAA CCT CCG CCG ATG AGC ATC 
exon 4 TGA TCA GTG GGT AGT AGT TTC TCT GG 
B0250.8 
exon 1/2 TTC GTC TTT CTC CAG GTA ACC CAA T 
exon 3 AGT GAA TTT GAT AAC TCC TGC GGC 
F35G12.2.2 
exon 1/2 ACA ACT AAG CTG GCT CGT TAT GG RT-qPCR 
reference gene exon 2 CAC TTC GAA ATC TAC TGG AGC TTG 
.
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Table.4.2.(continued)..Primer.sequences.
Target 
gene 
Target 
region Sequence Role 
pha-4 
1st ATG ACG AAG AGT CGT ATC AAG AGA CCT A 
ChIP 
1st ATG ATC AAT AAT GTC CTC ATC ACT GGA TGG 
intron 4 TGA AAG CTC TAA ATA TTT CCC AAG CA 
int 4/ex 5 GCC AGT GGT AAA ACC TGA ATG AGA T 
exon 7 CAA TCC CAG AAT TTC CTG AAC AAC AC 
intron 7 TAG TAG GGG GTC AAC AAA ACA TCG T 
3'UTR TTC AAC CGG CGT GCT TGT GT 
3'UTR GGC ATC TGG TAG AGG GGA ACC A 
eft-3 
promoter AGC GTT TTT CCT GTT CTC ACT GTT T 
Pol II ChIP 
positive ctrl 
gene 
promoter GAG TGC GGA CGG TAG AGA GAA TAA A 
elp-1 
ex 8/int 8 CAC ACT TGC GAT GTT AAA TGG TTT AG 
exon 9 CTA CCG AGT GGC ATG AAG ATT G 
srw-99 
promoter TCA AAA TGT TCC CAC GTC TAT AAA ACT TAC Pol II ChIP 
negative ctrl 
gene promoter AAA AAG AGC ATT TTG CAA TAC GTT AGA G 
pcaf-1 
exon 1 CGA CGA CAA TTA ACA TAT TTC ACG TC H3K9me3 
ChIP  
ctrl gene int 1/exon2 GTT CGA CAG TCT GAA AAA GCA GAA A 
.
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